Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3035999	li-laktaat	mmol/l (mmol/l)	3326	4030	0.25%
3035999	li-laktaat	— (—)	334	358	100.00%	Distribution not available
3035999	li-laktteh	mmol/l (mmol/l)	195	299	0.00%
3035999	li-laktteh	— (—)	45	65	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Fever of other and unknown origin

694

1180

5.17

314.78

1.3

1.2

2.15

2.12

mmol/l

0.23

647

1103

Headache

1116

1274

6.92

307.65

1.3

1.2

1.91

2.09

mmol/l

3.66

1035

1189

Hydrocephalus

283

176

17.53

307.65

2.2

1.2

2.39

2.26

mmol/l

0.37

268

164

Other degenerative diseases of the nervous system

475

219

16.25

307.65

1.2

1.1

1.83

2.09

mmol/l

2.77

444

197

Inflammatory diseases of the central nervous system

367

252

16.08

307.65

1.8

1.2

3.15

1.95

mmol/l

11.61

353

239

Symptoms and signs involving cognition, perception, emotional state and behaviour

1219

2223

3.71

307.65

1.3

2.02

2.14

mmol/l

1.95

1138

2062

Other symptoms and signs involving the nervous and musculoskeletal systems

694

1365

5.21

307.65

1.3

1.96

2.12

mmol/l

2.11

658

1275

Epilepsy

582

779

7.67

307.65

1.5

1.3

2.21

2.14

mmol/l

0.48

543

724

Neurological diseases

959

643

7.59

307.65

1.3

1.1

1.93

2.12

mmol/l

2.04

897

596

Other neurological diseases

1018

1832

4.39

307.65

1.5

1.2

2.11

2.16

mmol/l

0.35

948

1695

Symptoms and signs involving the nervous and musculoskeletal systems

959

1935

5.07

307.65

1.3

1.95

2.18

mmol/l

5.19

898

1793

Other symptoms and signs involving cognitive functions and awareness

708

1158

5.54

307.65

1.2

1.3

2.10

2.24

mmol/l

1.47

665

1065

General symptoms and signs

1206

1375

4.45

307.65

1.3

1.2

2.01

2.12

mmol/l

1.44

1128

1284

Intracranial trauma

517

475

7.43

296.68

1.4

1.1

2.07

1.97

mmol/l

0.62

467

441

Convulsions, not elsewhere classified

394

489

8.17

290.64

1.4

1.2

2.11

2.05

mmol/l

0.33

355

462

Concussion

441

472

7.32

267.94

1.3

1.1

2.03

1.97

mmol/l

0.26

398

438

Viral infections of the central nervous system, including avohilmo

270

234

12.45

266.03

1.4

1.3

2.21

1.96

mmol/l

3.05

256

216

Viral infections of the central nervous system

259

216

12.98

261.68

1.4

1.3

2.22

1.98

mmol/l

2.76

247

200

Focal epilepsy

418

654

6.61

254.86

1.4

1.2

2.21

2.05

mmol/l

1.33

388

607

Demyelinating diseases of the central nervous system

279

271

11.03

254.38

1.1

1.3

1.72

2.00

mmol/l

3.16

264

249

Neurological diseases, wide definition

355

119

15.22

254.14

1.3

1.1

1.84

1.90

mmol/l

0.27

329

110

Malaise and fatigue

599

952

5.03

254.08

1.3

1.2

2.05

2.17

mmol/l

1.07

554

890

Focal epilepsy, strict definition

396

605

6.78

247.21

1.4

1.2

2.18

2.07

mmol/l

0.85

368

562

Cerebrovascular diseases

860

1609

3.76

243.22

1.5

1.2

2.35

2.15

mmol/l

2.31

793

1502

Cerebrovascular diseases (FINNGEN)

508

637

5.72

233.96

1.6

1.1

2.38

1.95

mmol/l

4.62

469

598

Focal epilepsy, mode (most common among epilepsy diagnosis)

375

577

6.73

232.54

1.5

1.2

2.24

2.07

mmol/l

1.24

349

535

Meningitis

197

135

16.03

223.73

2.0

1.2

3.78

1.90

mmol/l

9.60

188

126

Abnormal findings on diagnostic imaging of central nervous system

202

153

14.47

216.78

1.4

1.99

2.00

mmol/l

0.01

187

142

Implicit Sepsis, including avohilmo

920

2026

3.28

215.69

1.3

2.16

2.05

mmol/l

1.14

857

1889

MS-disease / Multiple Sclerosis

225

208

11.56

212.17

1.1

1.3

1.67

1.91

mmol/l

5.36

210

192

Episodal and paroxysmal disorders

1078

1752

3.15

211.26

1.3

1.2

1.98

2.11

mmol/l

2.12

1004

1628

Condition for Implicit Sepsis (Organ dysfunction codes)

938

2051

3.20

209.77

1.3

2.11

2.05

mmol/l

0.59

876

1909

Implicit Sepsis

855

1902

3.35

209.07

1.3

2.18

2.05

mmol/l

1.51

794

1775

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

971

2139

3.10

203.97

1.3

2.07

2.04

mmol/l

0.34

912

1986

STROKE

671

1211

3.79

189.72

1.5

1.2

2.39

2.05

mmol/l

4.09

620

1130

Stroke, including SAH

693

1398

3.61

187.27

1.5

1.2

2.45

2.17

mmol/l

2.98

634

1300

Visual disturbances and blindness

643

1906

3.42

176.48

1.3

1.96

2.17

mmol/l

3.70

585

1786

Other demyelinating diseases of the central nervous system

152

108

15.49

169.32

1.1

1.5

1.75

1.96

mmol/l

1.24

146

100

Migraine

577

1228

3.70

166.52

1.2

1.82

2.03

mmol/l

4.13

542

1147

Hydrocephalus in other diseases

105.05

166.21

2.9

1.0

2.99

1.93

mmol/l

3.68

Visual disturbances

597

1773

3.42

163.80

1.3

1.92

2.16

mmol/l

4.69

547

1663

Postprocedural disorders of nervous system

189

198

10.08

162.89

1.3

1.2

1.70

2.01

mmol/l

2.16

176

186

Bacterial infection, other or unspecified

604

1505

3.43

159.45

1.3

2.36

2.06

mmol/l

3.86

559

1395

Bacterial infection, other or unspecified, including avohilmo

645

1644

3.26

155.56

1.4

1.3

2.35

2.05

mmol/l

4.36

598

1522

Implicit bacterial Sepsis

475

1044

3.96

154.88

1.3

2.33

2.09

mmol/l

2.11

433

970

Implicit bacterial Sepsis, including avohilmo

506

1129

3.78

153.40

1.3

2.31

2.09

mmol/l

1.96

463

1046

Bacterial Sepsis

513

1175

3.66

148.20

1.3

2.50

2.08

mmol/l

4.12

468

1091

Dizziness and giddiness

718

1890

2.98

148.00

1.3

1.97

2.16

mmol/l

3.75

667

1751

Cerebral cysts

155

143

11.48

146.18

1.3

1.2

1.77

2.07

mmol/l

2.62

146

132

Spirochaetal infections, other/unspecified

207

284

7.65

143.38

1.2

1.3

1.89

2.24

mmol/l

3.03

188

269

Implicit viral Sepsis, including avohilmo

378

902

4.26

141.95

1.3

2.19

2.04

mmol/l

0.85

352

838

Infections, IBD-co-morbidities

159

14.37

140.80

1.4

1.1

2.13

1.99

mmol/l

0.43

148

Implicit viral Sepsis

293

577

5.19

140.06

1.4

1.2

2.24

1.99

mmol/l

1.44

273

535

Other headache syndromes

440

1180

3.77

139.98

1.2

1.3

1.87

2.11

mmol/l

4.00

409

1104

Viral Sepsis

293

578

5.18

139.78

1.4

1.2

2.24

1.99

mmol/l

1.45

273

536

Stroke, excluding SAH

601

1349

3.25

139.77

1.4

1.3

2.34

2.21

mmol/l

0.87

549

1251

Abnormalities of gait and mobility

209

319

6.78

130.83

1.3

1.2

1.93

2.25

mmol/l

2.63

190

300

Certain infectious and parasitic diseases

822

1532

2.71

124.91

1.3

1.2

2.10

1.98

mmol/l

1.52

776

1420

Polyneuropathies and other disorders of the peripheral nervous system

301

675

4.56

123.26

1.2

2.05

2.20

mmol/l

1.20

283

634

Delirium, not induced by alcohol and other psychoactive substances

193

296

6.69

119.72

1.3

1.2

2.15

2.26

mmol/l

0.55

180

272

Pain, not elsewhere classified

279

601

4.71

119.69

1.3

1.94

2.10

mmol/l

1.15

251

566

Nontraumatic intracranial haemmorrhage

248

487

5.20

118.89

2.0

1.2

2.85

2.19

mmol/l

5.44

223

458

Aneurysms, operations, SAH

233

435

5.49

118.45

2.0

1.2

2.71

2.15

mmol/l

4.45

215

410

Sequelae of cerebrovascular disease

373

834

3.87

118.21

1.6

1.2

2.28

2.24

mmol/l

0.20

343

778

Other bacterial diseases

868

2370

2.44

117.41

1.3

2.37

2.02

mmol/l

6.08

800

2209

Normal-pressure hydrocephalus

119

109

11.58

112.84

1.5

1.1

2.08

2.24

mmol/l

0.39

113

100

Disorders of optic nerve and visual pathways

189

309

6.36

110.86

1.3

1.73

2.02

mmol/l

3.88

172

288

Disturbances of skin sensation

368

1037

3.61

109.91

1.2

1.3

1.70

2.04

mmol/l

14.93

337

973

Ischaemic Stroke, excluding all haemorrhages

526

1304

3.00

108.00

1.3

2.26

2.22

mmol/l

0.18

487

1203

Anaemias

243

283

5.58

105.89

1.2

1.1

2.08

1.74

mmol/l

3.56

225

267

Syncope and collapse

369

870

3.57

103.99

1.2

2.12

2.16

mmol/l

0.18

340

812

Autoimmune diseases excluding thyroid diseases, strict definition

898

2113

2.33

103.60

1.2

1.3

2.02

2.10

mmol/l

0.68

845

1958

Autoimmune diseases excluding thyroid diseases

922

2191

2.30

103.10

1.2

1.3

2.03

2.11

mmol/l

0.78

867

2033

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

259

229

5.72

102.76

1.4

1.2

1.97

2.20

mmol/l

0.86

243

208

Other and unspecified polyneuropathies, also in other diseases

255

587

4.44

101.11

1.2

2.04

2.21

mmol/l

1.15

239

551

Organic, including symptomatic, mental disorders

487

1139

3.04

100.98

1.2

1.3

2.15

2.27

mmol/l

0.94

451

1051

Malignant neoplasm of brain, including Hilmo

121

135

9.44

99.52

1.9

1.2

2.43

2.24

mmol/l

0.46

115

128

Medical observation and evaluation for suspected diseases and conditions

560

981

2.94

99.16

1.4

1.2

1.97

2.17

mmol/l

2.34

521

911

Subarachnoid haemorrhage

161

251

6.61

98.76

2.3

1.3

3.02

2.19

mmol/l

5.00

146

235

General examination and investigation of persons without complaint and reported diagnosis

551

981

2.94

98.07

1.3

1.2

2.02

2.17

mmol/l

1.66

517

911

Persons encountering health services in other circumstances

437

1449

3.02

97.87

1.3

1.2

2.09

2.07

mmol/l

0.07

408

1339

Autoimmune diseases related-to ILD

783

2868

2.30

97.66

1.2

1.3

1.97

2.12

mmol/l

2.87

729

2660

Speech disturbances, not elsewhere classified

165

268

6.38

97.38

1.5

1.2

2.17

2.20

mmol/l

0.09

154

251

Other disorders of fluid, electrolyte and acid-base balance

330

886

3.56

95.18

1.4

1.3

2.38

2.23

mmol/l

0.60

304

816

Alzheimer disease, excluding more controls

138

9.94

95.03

1.2

2.03

2.19

mmol/l

0.55

127

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

137

192

7.42

93.01

1.8

1.2

2.47

2.23

mmol/l

0.68

129

181

Migraine without aura

241

567

4.32

92.72

1.2

1.3

1.76

1.92

mmol/l

1.52

225

534

Traumatic subdural haemorrhage

109

103

10.04

92.59

1.5

1.1

2.43

2.20

mmol/l

0.61

Hypo-osmolality and hyponatraemia

218

471

4.68

92.38

1.5

1.3

2.39

2.22

mmol/l

0.47

201

438

741

1884

2.31

86.34

1.3

1.2

2.21

2.04

mmol/l

2.64

688

1754

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

741

1884

2.31

86.34

1.3

1.2

2.21

2.04

mmol/l

2.64

688

1754

ILD medications

945

2444

2.10

85.06

1.2

1.3

2.05

2.09

mmol/l

0.29

874

2274

Other bacterial diseases, including avohilmo

859

2522

2.14

84.59

1.3

1.2

2.30

1.99

mmol/l

5.65

800

2339

Malignant neoplasm of brain

10.41

84.50

1.8

1.3

2.35

2.11

mmol/l

0.73

Other antidepressants

834

1945

2.20

83.46

1.3

1.2

2.03

2.15

mmol/l

1.56

780

1808

Diplopia

188

398

4.84

82.89

1.3

1.97

2.19

mmol/l

1.32

171

373

Anxiety disorders, excluding more controls

680

1881

2.33

82.08

1.3

1.2

2.01

2.10

mmol/l

0.76

627

1760

Disorders of thyroid, IBD co-morbidities

119

9.24

80.95

1.5

1.1

2.23

1.95

mmol/l

0.90

113

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

834

2691

2.10

80.04

1.3

2.22

2.06

mmol/l

2.05

776

2507

Nausea and vomiting

291

840

3.42

80.03

1.3

2.07

2.10

mmol/l

0.15

277

780

Malignant neoplasm of eye, brain and central nervous system

101

119

8.91

79.61

1.9

1.3

2.36

2.11

mmol/l

0.88

112

Persons encountering health services for specific procedures and health care

900

2593

2.06

79.43

1.4

1.2

2.14

2.01

mmol/l

1.87

827

2427

Low back pain

672

1999

2.29

79.08

1.2

1.3

1.93

2.15

mmol/l

4.61

614

1864

Influenza and pneumonia

893

2702

2.05

78.75

1.3

1.2

2.16

2.03

mmol/l

1.87

829

2515

Opioids

812

1950

2.16

78.19

1.3

2.02

2.07

mmol/l

0.45

748

1822

Mood disorders, excluding more controls

745

1995

2.21

78.13

1.3

1.2

2.06

2.12

mmol/l

0.58

692

1865

Pneumonia, organism unspecified

779

2519

2.13

78.05

1.3

2.19

2.06

mmol/l

1.87

722

2344

Explicit Sepsis

390

1257

2.85

77.70

1.4

1.3

2.59

2.05

mmol/l

5.19

359

1167

Dorsalgia

820

2041

2.14

77.60

1.3

1.96

2.15

mmol/l

3.52

755

1902

Explicit Sepsis, including avohilmo

395

1284

2.82

76.70

1.4

1.3

2.59

2.06

mmol/l

5.05

364

1192

First line medication for Crohn's disease

900

2375

2.05

76.56

1.3

1.2

2.09

2.03

mmol/l

0.59

829

2213

Benzodiazepine use

851

2826

2.04

76.04

1.3

2.00

2.12

mmol/l

2.42

792

2622

Other soft tissue disorders, not elsewhere classified

804

2167

2.12

75.96

1.2

1.3

1.92

2.13

mmol/l

4.43

753

2010

ILD medications: prednisolone, methylprednisolone, prednisone

883

2409

2.05

75.67

1.3

2.11

2.09

mmol/l

0.07

813

2239

Symptoms and signs involving the skin and subcutaneous tissue

637

2735

2.22

74.92

1.2

1.3

1.86

2.15

mmol/l

9.00

591

2541

Complications of medical and surgical care

641

2620

2.21

74.61

1.6

1.2

2.22

2.10

mmol/l

1.23

601

2428

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

575

2170

2.32

74.51

1.3

2.10

2.17

mmol/l

0.68

536

2009

ILD medications: immunosuppressive drugs

564

2231

2.31

72.51

1.3

2.10

2.09

mmol/l

0.01

530

2081

Nerve, nerve root and plexus disorders

875

2635

2.01

72.25

1.2

1.3

2.04

2.13

mmol/l

1.05

819

2447

Migraine with aura

247

706

3.54

72.18

1.2

1.3

1.81

2.01

mmol/l

2.15

233

665

Septicaemia

370

1212

2.81

71.74

1.4

1.3

2.63

2.08

mmol/l

4.79

341

1122

Anxiety disorders

763

2536

2.08

71.38

1.3

1.98

2.10

mmol/l

1.43

707

2364

Oedema, not elsewhere classified

247

693

3.51

71.13

1.3

2.05

2.22

mmol/l

1.11

231

646

Used for control exclusion in common control thyroid runs

821

2004

2.08

71.05

1.3

1.96

2.10

mmol/l

2.41

763

1858

Other septicaemia, including avohilmo

345

1131

2.89

71.00

1.4

1.3

2.35

2.08

mmol/l

3.21

318

1048

Other septicaemia

339

1108

2.91

70.83

1.4

1.3

2.35

2.08

mmol/l

3.15

312

1029

Neurotic, stress-related and somatoform disorders

756

2527

2.07

70.52

1.3

1.98

2.10

mmol/l

1.62

701

2355

All pneumoniae

843

2754

2.00

70.38

1.3

1.2

2.17

2.04

mmol/l

2.04

779

2565

Parasetamol

566

1186

2.43

70.24

1.3

1.2

1.98

2.02

mmol/l

0.24

522

1109

Pneumonias (Asthma/COPD co-morbidities)

837

2745

2.00

70.23

1.3

1.2

2.17

2.04

mmol/l

2.12

774

2555

Other dorsopathies, not elsewhere classified

809

2043

2.07

69.84

1.2

1.3

1.89

2.14

mmol/l

6.92

747

1904

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

819

2746

2.00

68.54

1.3

1.2

2.17

2.06

mmol/l

1.52

755

2556

Any mental disorder

822

2023

2.05

68.31

1.3

1.2

2.09

2.12

mmol/l

0.24

756

1889

Bleeding

671

2214

2.14

68.08

1.5

1.2

2.44

2.09

mmol/l

5.92

610

2066

Complications of surgical and medical care, not elsewhere classified

816

2752

1.99

67.59

1.5

1.2

2.18

2.08

mmol/l

1.12

768

2545

Other disorders of optic [2nd] nerve and visual pathways

115

192

6.21

66.18

1.4

1.3

1.75

2.00

mmol/l

2.57

103

180

Autoimmune diseases

856

2202

1.98

65.71

1.2

1.3

1.99

2.11

mmol/l

1.97

798

2043

Intracranial injury

516

2118

2.29

65.49

1.4

1.2

2.02

2.10

mmol/l

0.87

462

1980

Other special examinations and investigations of persons without complaint or reported diagnosis

486

981

2.53

65.45

1.3

1.2

2.04

2.17

mmol/l

1.02

449

911

Cerebral palsy and other paralytic syndromes

156

345

4.63

65.30

1.9

1.2

2.00

2.12

mmol/l

0.53

145

323

Persons encountering health services in other circumstances, wide

880

2344

1.94

63.72

1.3

1.2

2.09

2.11

mmol/l

0.14

826

2163

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

518

2280

2.24

63.47

1.6

1.2

2.21

2.11

mmol/l

0.82

487

2110

Oral corticosteroids

851

2590

1.94

63.42

1.3

2.13

2.09

mmol/l

0.27

786

2409

Mood [affective] disorders

822

2730

1.94

62.79

1.3

2.02

2.11

mmol/l

1.13

760

2540

Myalgia

263

854

3.12

62.74

1.2

1.4

1.89

2.07

mmol/l

1.87

243

798

Mood disorders

822

2733

1.93

62.25

1.3

2.02

2.11

mmol/l

1.17

760

2543

Diseases of the eye and adnexa

634

1465

2.18

61.94

1.3

1.2

1.93

2.10

mmol/l

2.15

590

1372

Parkinson's disease, excluding more controls

100

8.00

61.18

1.2

1.93

2.22

mmol/l

1.28

Depression medications

230

303

3.85

60.14

1.4

1.1

1.91

1.73

mmol/l

1.46

217

287

Any gastric operation

590

1349

2.21

59.29

1.4

1.2

1.99

mmol/l

0.05

548

1259

GASTRO-related operations

590

1349

2.21

59.29

1.4

1.2

1.99

mmol/l

0.05

548

1259

Persons with potential health hazards related to communicable diseases

374

1498

2.50

58.54

1.3

1.92

mmol/l

0.00

360

1400

COPD/asthma related infections

746

1884

1.99

57.99

1.3

1.2

2.10

2.04

mmol/l

0.55

689

1754

COPD/asthma/ILD related infections

746

1884

1.99

57.99

1.3

1.2

2.10

2.04

mmol/l

0.55

689

1754

Bell's palsy

151

359

4.30

57.65

1.2

1.3

2.05

2.11

mmol/l

0.20

145

331

Depression

763

2668

1.92

57.46

1.3

2.02

2.10

mmol/l

0.90

699

2485

All kidney diseases

782

2763

1.91

57.44

1.3

1.2

2.16

2.05

mmol/l

1.38

727

2569

Inflammatory bowel disease treatment related agents

890

2678

1.85

57.40

1.3

2.11

2.07

mmol/l

0.27

824

2491

Tramadol

611

1762

2.10

57.00

1.3

2.08

2.10

mmol/l

0.14

561

1643

Parkinson's disease, strict definition, excluding more controls

8.17

56.84

1.2

1.95

2.28

mmol/l

1.33

Pain in joint

432

1106

2.41

56.36

1.1

1.2

1.93

2.22

mmol/l

3.76

396

1022

Certain infectious and parasitic diseases, including avohilmo

503

1097

2.31

56.18

1.3

2.12

2.02

mmol/l

0.74

471

1020

Psychiatric diseases

696

1738

2.02

55.82

1.3

1.2

2.07

2.14

mmol/l

0.63

645

1624

Persons encountering health services for other counselling and medical advice, not elsewhere classified

826

2340

1.88

55.58

1.3

1.2

2.08

2.11

mmol/l

0.27

779

2159

Benign neoplasm of meninges

133

296

4.60

55.32

1.5

1.2

2.55

2.22

mmol/l

1.01

117

274

Contact with and exposure to communicable diseases

318

1218

2.63

55.28

1.2

1.3

1.91

1.89

mmol/l

0.10

305

1135

Lower back pain or/and sciatica

842

2855

1.84

54.85

1.2

1.3

1.93

2.14

mmol/l

5.59

772

2661

Provisional assignment of new diseases of uncertain etiology

458

2063

2.22

54.76

1.3

2.05

2.07

mmol/l

0.09

430

1911

Migraine without aura and triptan purchases

200

599

3.39

54.67

1.1

1.3

1.76

1.96

mmol/l

1.89

186

563

Codes for special purposes

458

2065

2.22

54.61

1.3

1.2

2.05

2.07

mmol/l

0.08

430

1913

Cardiovascular diseases (excluding rheumatic etc)

528

1387

2.19

54.26

1.3

1.2

2.00

1.83

mmol/l

2.67

489

1295

Other reaction to severe stress, and adjustment disorders

342

1378

2.50

53.92

1.3

2.06

1.99

mmol/l

0.33

312

1289

Symptoms and signs involving the urinary system

600

2253

2.02

53.47

1.3

2.17

2.14

mmol/l

0.14

557

2091

Renal tubulo-interstitial diseases

679

2583

1.94

53.34

1.4

1.2

2.24

2.05

mmol/l

2.51

631

2405

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

251

858

2.92

53.32

1.3

2.00

1.93

mmol/l

0.55

229

807

Pain in limb

658

2127

1.98

53.14

1.2

1.3

1.97

2.13

mmol/l

2.53

615

1975

Pain (limb, back, neck, head abdominally)

506

1139

2.24

52.69

1.3

1.2

2.04

2.22

mmol/l

1.73

477

1049

Injuries to the head

862

2840

1.81

52.50

1.3

1.2

2.06

2.09

mmol/l

0.25

794

2646

Subjective visual disturbances

252

885

2.88

52.41

1.2

1.3

1.79

2.12

mmol/l

6.98

230

830

Symptoms and signs involving speech and voice

305

1182

2.61

52.35

1.3

2.08

2.12

mmol/l

0.19

283

1103

Substance abuse, excluding more controls

427

1583

2.27

52.25

1.3

2.21

2.10

mmol/l

0.85

395

1485

Covid-19 confirmed case

330

1329

2.50

52.06

1.4

1.3

2.14

2.09

mmol/l

0.24

309

1233

Hypothyroidism (congenital or acquired)

194

290

3.78

51.84

1.2

1.1

1.92

1.74

mmol/l

1.65

179

275

Paralytic strabismus

102

192

5.47

51.71

1.5

1.2

2.06

2.12

mmol/l

0.18

179

Hypothyroidism and >3 levothyroxin purchases

192

289

3.75

50.95

1.2

1.1

1.92

1.74

mmol/l

1.71

178

274

Hypothyroidism, levothyroxine purchases

192

289

3.75

50.95

1.2

1.1

1.92

1.74

mmol/l

1.71

178

274

Abnormal involuntary movements

145

367

4.02

50.89

1.4

1.3

1.89

2.18

mmol/l

2.44

132

344

Spirochaetal infections, other/unspecified, including avohilmo

311

1237

2.54

50.61

1.2

1.3

1.91

2.14

mmol/l

3.89

283

1155

Other anxiety disorders

416

1578

2.26

50.58

1.2

1.3

1.83

2.00

mmol/l

2.74

385

1478

Cerebral aneurysm, nonruptured

107

215

5.09

50.33

1.7

1.2

2.25

2.24

mmol/l

0.03

202

Codeine

686

1927

1.93

50.08

1.2

1.3

2.02

2.07

mmol/l

0.50

624

1799

Dorsopathies

759

2056

1.88

50.03

1.2

1.3

1.91

2.14

mmol/l

5.36

705

1915

Benign neoplasm: Cerebral meninges

120

268

4.59

49.74

1.3

2.57

2.14

mmol/l

1.41

105

249

Cardiovascular diseases

490

1193

2.19

49.48

1.3

1.2

1.95

1.83

mmol/l

1.43

455

1116

Other spirochaetal diseases, including avohilmo

312

1258

2.51

49.34

1.2

1.3

1.91

2.13

mmol/l

3.59

284

1176

Lyme disease

307

1229

2.53

49.30

1.2

1.3

1.91

2.14

mmol/l

3.85

279

1149

Lyme disease, including avohilmo

307

1229

2.53

49.30

1.2

1.3

1.91

2.14

mmol/l

3.85

279

1149

Other spirochaetal diseases

309

1241

2.52

49.28

1.2

1.3

1.92

2.14

mmol/l

3.46

281

1159

Dementia

323

868

2.57

49.17

1.2

2.12

2.35

mmol/l

1.59

299

798

Any death

479

1574

2.14

49.06

1.4

1.3

2.56

2.14

mmol/l

5.65

441

1466

Hard cardiovascular diseases

616

1853

1.98

48.86

1.4

1.2

2.23

2.14

mmol/l

0.77

571

1726

Metabolic disorders

709

2277

1.88

48.68

1.3

2.20

2.07

mmol/l

1.06

660

2114

Care involving use of rehabilitation procedures

495

2168

2.07

48.58

1.4

1.2

2.07

2.05

mmol/l

0.11

449

2027

Dementia, including avohilmo

350

981

2.45

48.57

1.2

2.12

2.32

mmol/l

1.57

323

904

Depression or dysthymia

441

1069

2.26

48.49

1.3

1.2

1.99

2.18

mmol/l

2.28

407

997

Anxiety (asthma-related co-morbidities)

496

1822

2.08

48.09

1.2

1.3

1.88

2.03

mmol/l

2.41

458

1711

Other disorders of urethra and urinary system

546

1891

2.02

47.92

1.4

1.2

2.18

2.12

mmol/l

0.40

506

1751

Oxycodone

320

1116

2.47

47.67

1.4

1.3

2.22

2.18

mmol/l

0.23

295

1045

Abnormalities of breathing

673

2034

1.90

47.55

1.3

1.96

2.10

mmol/l

2.10

623

1894

Fitting and adjustment of other devices

294

1021

2.56

47.35

1.3

1.2

2.39

2.14

mmol/l

1.49

269

948

Invasive ventilation

108

231

4.81

47.29

1.4

1.3

2.89

2.17

mmol/l

2.47

218

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

461

2223

2.08

47.12

1.7

1.2

2.22

2.13

mmol/l

0.61

435

2054

Other pulmonary diagnosis

544

1326

2.07

46.68

1.4

1.2

2.04

2.10

mmol/l

0.39

504

1238

Acute sinusitis

429

1839

2.13

46.02

1.2

1.3

2.12

2.05

mmol/l

0.36

390

1722

Strabismus

259

985

2.65

46.00

1.4

1.2

1.95

1.99

mmol/l

0.25

235

925

819

2345

1.78

45.51

1.2

1.3

2.06

2.12

mmol/l

0.50

760

2180

Continuous positive airway pressure

163

390

3.52

45.22

1.3

1.2

2.09

2.02

mmol/l

0.30

153

377

Disorders of ocular muscles, binocular movement, accommodation and refraction

411

1922

2.14

44.81

1.4

1.2

1.98

2.03

mmol/l

0.42

377

1807

Symptoms and signs involving the circulatory and respiratory systems

739

2037

1.83

44.66

1.3

1.97

2.10

mmol/l

1.77

686

1896

Implicit fungal Sepsis, including avohilmo

180

5.23

44.66

1.2

1.3

2.45

1.94

mmol/l

0.99

168

All anxiety disorders

507

1976

2.00

44.51

1.2

1.3

1.87

2.05

mmol/l

3.26

468

1848

Excluding asthma or asthma-COPD overlap

536

1326

2.03

44.29

1.4

1.2

2.05

2.10

mmol/l

0.30

497

1238

Acute upper respiratory infections

759

2567

1.78

44.07

1.2

1.3

2.05

2.12

mmol/l

0.71

699

2389

COPD differential diagnosis

535

1327

2.03

43.91

1.4

1.2

2.05

2.10

mmol/l

0.34

496

1240

Acute upper respiratory infections of multiple and unspecified sites

583

2249

1.90

43.47

1.3

1.89

2.08

mmol/l

4.64

543

2101

ILD differential diagnosis

533

1327

2.02

43.32

1.4

1.2

2.05

2.10

mmol/l

0.33

494

1240

Primary_lymphoid and hematopoietic malignant neoplasms

212

754

2.85

43.17

1.4

1.2

2.35

2.18

mmol/l

0.65

200

706

Exclusions for E4_PCOS_BROAD

188

626

3.05

43.11

1.3

2.09

2.05

mmol/l

0.17

170

583

Selective serotonin reuptake inhibitors

687

1952

1.84

42.80

1.3

1.2

1.99

2.15

mmol/l

2.95

640

1815

Visual field defects

104

235

4.53

42.53

1.6

1.3

2.31

2.25

mmol/l

0.10

219

Any reimbursement code in KELA

431

995

2.18

42.49

1.3

1.2

1.96

1.94

mmol/l

0.08

404

926

Acute tubulo-interstitial nephritis

488

2089

1.98

42.41

1.4

1.3

2.25

2.08

mmol/l

1.63

453

1945

Any dementia, excluding more controls

263

691

2.63

42.36

1.2

2.08

2.30

mmol/l

1.75

242

642

Disorders of other endocrine glands

369

1680

2.18

42.30

1.2

1.3

2.01

2.05

mmol/l

0.24

341

1570

Dysphagia

210

759

2.80

41.47

1.4

1.3

2.14

2.20

mmol/l

0.23

194

705

Intracerebral haemorrhage

119

304

3.97

41.27

2.1

1.2

2.80

2.21

mmol/l

2.28

102

286

Systemic connective tissue disorders

294

1255

2.36

41.08

1.2

1.3

2.11

2.10

mmol/l

0.05

267

1165

Other diseases of urinary system

710

2245

1.78

40.93

1.4

1.2

2.09

2.08

mmol/l

0.05

664

2086

Somnolence, stupor and coma

6.87

40.89

1.4

2.10

2.04

mmol/l

0.16

Enlarged lymph nodes

121

316

3.87

40.64

1.2

1.3

2.29

2.10

mmol/l

0.40

115

300

Complications of procedures, not elsewhere classified

599

2648

1.83

40.61

1.4

1.2

2.17

2.09

mmol/l

0.60

561

2452

Viral infections characterized by skin and mucous membrane lesions

354

1639

2.18

40.58

1.3

2.22

2.06

mmol/l

0.95

337

1528

Bronchitis

795

2801

1.71

40.23

1.2

1.3

1.97

2.12

mmol/l

2.90

746

2592

Symptoms and signs involving the digestive system and abdomen

693

1936

1.80

40.20

1.3

1.2

2.02

2.14

mmol/l

1.37

658

1784

Liquid cancers

243

905

2.57

40.06

1.4

1.3

2.32

2.20

mmol/l

0.43

227

841

Pain in throat and chest

613

1981

1.84

39.64

1.2

1.3

1.97

2.12

mmol/l

2.19

560

1844

Migraine with aura and triptan purchases

173

578

3.04

39.55

1.2

1.3

1.80

1.95

mmol/l

0.99

162

543

Persons encountering health services for examination and investigation

417

981

2.14

39.37

1.3

1.2

2.05

2.17

mmol/l

0.97

389

911

Exposure to unspecified factor

755

3021

1.71

39.03

1.3

1.2

2.06

2.09

mmol/l

0.16

693

2813

Intestinal infectious diseases

703

3034

1.73

38.81

1.3

1.2

1.98

2.10

mmol/l

2.56

651

2818

Gastro-oesophageal reflux disease

512

2295

1.89

38.80

1.3

2.01

2.17

mmol/l

1.97

473

2132

Alzheimer’s disease (Late onset), excluding more controls

6.83

38.79

1.2

2.09

2.30

mmol/l

0.51

Recurrent or chronic depression

281

806

2.43

38.77

1.2

1.88

2.11

mmol/l

2.67

262

755

Diseases of the myoneural junction and muscle

132

379

3.54

38.72

1.3

2.18

2.17

mmol/l

0.05

118

355

Extrapyramidal and movement disorders

302

1339

2.27

38.64

1.2

1.3

1.95

2.20

mmol/l

4.62

279

1246

Diarrhoea and gastroenteritis of presumed infectious origin

540

2623

1.85

38.39

1.3

1.2

1.98

2.09

mmol/l

1.64

497

2433

Non-invasive ventilation

191

580

2.87

38.31

1.7

1.2

2.30

2.05

mmol/l

1.54

170

555

Other functional intestinal disorders

368

1600

2.10

38.12

1.3

1.97

2.18

mmol/l

3.54

336

1474

Other/unspecified dorsalgia

288

1242

2.31

38.07

1.2

1.3

1.98

2.17

mmol/l

1.75

261

1167

Agranulocytosis

124

348

3.63

37.69

1.5

1.3

2.53

2.15

mmol/l

0.99

119

327

Asthma, unspecified (mode), excluding more controls

354

1177

2.16

37.59

1.3

1.2

2.17

2.09

mmol/l

0.37

328

1105

Diseases of oesophagus, stomach and duodenum

759

2663

1.69

36.76

1.3

2.03

2.13

mmol/l

1.16

704

2472

Asthma, unspecified (mode)

358

1229

2.11

35.92

1.3

1.2

2.17

2.10

mmol/l

0.33

331

1152

Personality disorders, excluding more controls

210

815

2.59

35.92

1.2

1.3

1.88

1.93

mmol/l

0.35

186

771

Other diseases of blood and blood-forming organs, wide

197

744

2.68

35.86

1.4

1.3

2.39

2.10

mmol/l

1.22

183

698

Liquid cancers, including Hilmo

277

1067

2.31

35.81

1.3

2.35

2.18

mmol/l

0.82

258

993

Other anaemias

316

1371

2.17

35.79

1.3

2.37

2.19

mmol/l

0.87

290

1271

Other and unspecified anaemias

314

1364

2.18

35.74

1.3

2.37

2.18

mmol/l

0.99

288

1264

Fall on same level

820

2656

1.65

35.72

1.3

2.06

2.07

mmol/l

0.14

762

2470

Asthma, excluding more controls

476

1258

1.95

35.46

1.3

1.2

2.05

2.10

mmol/l

0.29

441

1177

Pneumonitis due to solids and liquids

216

4.29

34.97

1.8

1.2

2.44

2.18

mmol/l

0.70

197

Soft tissue disorders

722

2181

1.70

34.83

1.2

1.3

1.96

2.13

mmol/l

2.74

680

2023

Diagnoses used for exclusion with ILD

211

836

2.55

34.81

1.5

1.2

2.33

2.13

mmol/l

1.18

198

788

Neuromuscular dysfunction of bladder

101

260

3.96

34.81

1.4

1.2

2.04

2.17

mmol/l

0.44

240

Other and unspecified visual disturbances

115

325

3.60

34.61

1.1

1.2

1.83

2.20

mmol/l

3.59

104

305

Brain meningioma, including Hilmo

143

5.18

34.49

1.5

1.2

2.65

2.26

mmol/l

0.79

133

Aplastic and other anaemias

336

1481

2.09

34.33

1.3

2.34

2.17

mmol/l

0.89

307

1372

Spondylopathies

526

1695

1.84

34.30

1.3

2.18

2.22

mmol/l

0.22

486

1577

Benign neoplasm of brain and other parts of central nervous system

191

4.51

34.20

2.1

1.2

2.69

2.03

mmol/l

2.13

177

Asthma (mode)

481

1327

1.91

34.06

1.3

1.2

2.05

2.10

mmol/l

0.31

445

1240

Brain meningioma

141

5.18

34.02

1.5

1.2

2.64

2.15

mmol/l

1.21

132

Fungal Sepsis

102

6.05

33.98

1.1

2.68

1.90

mmol/l

1.06

Other intervertebral disc disorders

556

1850

1.80

33.67

1.2

1.3

1.98

2.19

mmol/l

3.34

513

1723

Asthma

482

1313

1.90

33.42

1.3

1.2

2.05

2.10

mmol/l

0.31

446

1226

Hypertensive diseases (excluding secondary)

370

1049

2.06

33.19

1.3

1.2

2.13

1.89

mmol/l

2.76

342

979

Other medical care

349

1441

2.04

33.15

1.5

1.2

2.49

2.09

mmol/l

3.56

326

1344

Codeine or tramadol medication

796

2664

1.63

33.03

1.2

1.3

2.07

2.10

mmol/l

0.24

723

2484

Brain glioblastoma and astrocytoma

8.86

32.91

1.5

1.2

2.21

1.88

mmol/l

1.26

Any dementia

269

820

2.28

32.31

1.2

2.08

2.35

mmol/l

2.40

248

750

Abdominal and pelvic pain

657

1936

1.71

32.18

1.3

1.2

1.99

2.14

mmol/l

2.32

621

1784

Antihypertensive medication - note that there are other indications

458

1263

1.90

32.01

1.3

1.2

1.87

1.92

mmol/l

0.40

418

1191

Diseases of the ear and mastoid process

792

2455

1.62

31.80

1.2

1.3

1.97

2.10

mmol/l

1.97

730

2287

Implicit fungal Sepsis

6.01

31.46

1.1

2.66

1.89

mmol/l

0.91

All influenza

205

841

2.46

31.42

1.2

2.09

2.03

mmol/l

0.20

186

796

Hypertension, essential

540

1722

1.78

31.23

1.3

2.25

2.00

mmol/l

2.88

499

1600

Cystitis

578

1986

1.74

31.17

1.3

1.2

2.03

2.10

mmol/l

0.63

537

1842

Other specific joint derangements/joint disorders

544

1932

1.76

31.09

1.2

1.3

1.94

2.05

mmol/l

1.28

501

1789

Other and unspecified myopathies

242

3.87

30.81

1.2

1.3

2.16

2.21

mmol/l

0.15

227

Constipation

622

2515

1.68

30.66

1.3

2.05

2.14

mmol/l

1.08

574

2340

Disorders of vestibular function (Vertigo)

339

1672

1.99

30.60

1.2

1.3

1.92

2.24

mmol/l

7.51

317

1550

Sleep apnoea

654

2485

1.67

30.60

1.2

1.3

2.06

2.16

mmol/l

1.14

603

2298

Other symptoms and signs involving the digestive system and abdomen

145

508

2.89

30.53

1.2

1.3

2.07

2.12

mmol/l

0.14

134

467

Transient ischemic attack

331

1308

2.03

30.47

1.2

1.3

2.12

2.23

mmol/l

0.81

307

1207

Schizophrenia or delusion, excluding more controls

219

927

2.35

30.37

1.2

1.3

2.15

2.02

mmol/l

0.55

199

874

Substance abuse

427

2171

1.84

30.18

1.3

2.21

2.08

mmol/l

1.05

395

2031

Zoster [herpes zoster]

157

578

2.75

30.13

1.3

1.2

2.22

2.15

mmol/l

0.23

149

535

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

687

2661

1.64

30.12

1.4

1.2

2.18

2.05

mmol/l

1.14

633

2479

Mental and behavioural disorders due to psychoactive substance use

437

2206

1.82

30.11

1.2

1.3

2.21

2.08

mmol/l

1.03

404

2064

Other joint disorders

632

1962

1.69

29.73

1.2

1.3

1.91

2.05

mmol/l

2.41

595

1816

Supplementary factors related to causes of morbidity and mortality classified elsewhere

256

1185

2.18

29.65

1.4

1.2

2.03

2.06

mmol/l

0.16

237

1111

Migraine, single triptan purchase ok & required. ICD-code if available is included

554

2193

1.72

29.55

1.3

1.83

2.09

mmol/l

7.47

514

2050

Triptan medication for migraine, single purchase ok

554

2193

1.72

29.55

1.3

1.83

2.09

mmol/l

7.47

514

2050

Examination and observation for other reasons

346

974

2.01

28.97

1.3

1.2

2.04

2.18

mmol/l

0.83

323

906

L04AX Other immunosuppressants

412

2268

1.83

28.91

1.3

2.16

2.09

mmol/l

0.29

387

2107

Hypopituitarism

235

3.82

28.88

1.2

1.4

2.12

1.97

mmol/l

0.57

220

Falls/tendency to fall

724

2251

1.62

28.74

1.3

2.02

2.08

mmol/l

0.51

676

2093

Type of accident

238

1084

2.21

28.72

1.4

1.2

1.98

2.07

mmol/l

0.64

219

1017

Spondylosis

364

1488

1.92

28.72

1.3

2.09

2.26

mmol/l

1.47

338

1393

Other disorders of lacrimal gland

288

1413

2.05

28.64

1.2

1.3

2.15

mmol/l

0.02

260

1309

Endocrine, nutritional and metabolic diseases

546

1590

1.74

28.54

1.3

1.2

2.02

1.97

mmol/l

0.40

502

1490

Other disorders of nervous system

180

4.25

28.51

1.6

1.2

2.15

2.30

mmol/l

0.40

168

Second line medication for Crohn's disease

424

2369

1.80

28.29

1.3

2.15

2.08

mmol/l

0.29

398

2203

Hypothyroidism, strict autoimmune

465

1714

1.79

28.28

1.3

1.97

2.13

mmol/l

2.43

423

1592

Asthma (only as main-diagnosis), excluding more controls

422

1258

1.86

28.11

1.3

1.2

1.98

2.10

mmol/l

0.85

388

1177

Diseases of the musculoskeletal system and connective tissue

369

946

1.96

28.05

1.2

1.3

1.94

2.12

mmol/l

1.48

346

879

Visual impairment including blindness (binocular or monocular)

174

4.27

27.98

1.3

1.2

2.16

2.02

mmol/l

0.27

165

Unspecified fall

370

1955

1.87

27.88

1.2

1.3

2.00

2.11

mmol/l

1.19

341

1815

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

251

1184

2.14

27.75

1.3

2.00

1.94

mmol/l

0.51

229

1111

Cervicalgia

167

661

2.55

27.74

1.3

1.95

2.14

mmol/l

1.49

152

624

Volume depletion

219

3.84

27.66

1.3

1.2

2.34

2.19

mmol/l

0.33

206

Factors influencing health status and contact with health services

172

315

2.75

27.66

1.3

1.1

1.99

2.02

mmol/l

0.15

161

292

Dental caries

204

832

2.33

27.58

1.3

1.2

2.13

mmol/l

0.00

188

783

Accidents

536

1556

1.73

27.56

1.3

2.03

2.12

mmol/l

0.69

496

1455

Other external causes of accidental injury

536

1556

1.73

27.56

1.3

2.02

2.12

mmol/l

0.88

498

1455

Focal brain injury

7.35

27.56

1.5

1.0

2.66

2.16

mmol/l

0.63

Other disorders of bladder

105

325

3.27

27.48

1.3

1.2

2.09

2.21

mmol/l

0.42

306

Other necrotizing vasculopathies (FG)

156

4.45

27.42

1.4

1.3

2.25

2.12

mmol/l

0.26

148

Disorders of lacrimal system

328

1684

1.93

27.24

1.3

2.14

2.13

mmol/l

0.04

300

1559

Abnormalities of heart beat

263

1230

2.09

27.23

1.2

1.3

2.05

2.15

mmol/l

0.44

245

1140

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

639

3104

1.61

27.20

1.3

2.11

2.07

mmol/l

0.28

595

2884

Presence of other devices

177

715

2.46

27.10

1.3

1.2

2.38

2.23

mmol/l

0.52

161

670

Hemiplegia

126

4.87

26.96

1.9

1.2

1.85

2.03

mmol/l

1.11

119

Caries of dentine

183

736

2.42

26.95

1.2

2.16

2.15

mmol/l

0.01

168

692

L04AA Selective immunosuppressants

192

824

2.35

26.77

1.2

1.3

2.24

2.06

mmol/l

0.49

180

769

Other systemic involvement of connective tissue (FG)

199

852

2.31

26.58

1.2

1.3

2.01

2.11

mmol/l

0.42

183

794

Asthma (only as main-diagnosis)

426

1313

1.82

26.57

1.3

1.2

1.98

2.10

mmol/l

0.96

392

1226

Presence of other functional implants

386

1434

1.85

26.56

1.3

2.35

2.22

mmol/l

0.54

360

1335

Lumbar disc prolapse

424

1771

1.78

26.14

1.2

1.3

1.96

2.19

mmol/l

3.46

394

1649

Gastrointestinal diseases

416

1138

1.84

26.11

1.3

1.2

1.95

2.06

mmol/l

0.92

383

1053

Hypertension

531

1773

1.70

26.06

1.3

2.21

1.99

mmol/l

2.41

492

1649

Hypertensive diseases

531

1774

1.69

26.02

1.3

2.21

1.99

mmol/l

2.41

492

1650

Symptoms and signs concerning food and fluid intake

201

3.86

25.96

1.2

1.3

1.96

2.13

mmol/l

0.40

188

Sleep disorders (combined)

731

2442

1.57

25.95

1.2

1.3

1.98

2.13

mmol/l

2.61

667

2269

Sleep apnoea, including avohilmo

673

2575

1.59

25.81

1.2

1.3

2.05

2.14

mmol/l

0.97

624

2384

Sciatica+with lumbago

349

1666

1.86

25.76

1.2

1.3

1.94

2.20

mmol/l

4.30

321

1553

Somatoform disorder

142

542

2.65

25.48

1.2

1.3

1.81

2.04

mmol/l

1.87

128

506

Cervical disc disorders

245

1187

2.08

25.27

1.4

1.3

2.02

2.21

mmol/l

1.59

225

1112

Pain in thoracic spine

126

455

2.80

25.18

1.5

1.3

1.82

2.12

mmol/l

3.09

121

430

Other necrotizing vasculopathies

202

3.83

25.17

1.3

1.2

2.23

2.17

mmol/l

0.11

189

Triptan medication for migraine, min. 3 purchases

420

1788

1.76

25.12

1.2

1.3

1.82

2.01

mmol/l

3.49

393

1668

Other and unspecified nonorganic psychotic disorders

172

725

2.40

25.02

1.2

1.3

2.15

1.93

mmol/l

1.01

157

672

Certain disorders involving the immune mechanism

161

660

2.47

24.92

1.5

1.3

2.24

2.09

mmol/l

0.60

154

618

Diseases of inner ear

370

1973

1.80

24.88

1.2

1.3

1.93

2.22

mmol/l

7.15

343

1824

Unspecific neurodegenerative disorder

264

881

2.06

24.83

1.2

2.13

2.34

mmol/l

1.23

245

808

Tick-borne viral encephalitis, including avohilmo

29.65

24.82

1.2

1.3

2.19

1.85

mmol/l

0.81

Intestinal infectious diseases, including avohilmo, including avohilmo

767

2802

1.53

24.70

1.3

2.02

2.12

mmol/l

1.48

716

2599

Bipolar affective disorders

159

652

2.46

24.58

1.2

1.3

2.06

1.94

mmol/l

0.44

152

614

Disorders of eyelid, lacrimal system and orbit

587

2695

1.60

24.39

1.3

2.11

2.10

mmol/l

0.04

539

2511

Radiculopathy

124

452

2.77

24.35

1.2

1.3

2.01

2.18

mmol/l

1.03

111

424

Other CVD (FINNGEN)

207

3.43

24.13

1.3

1.2

2.07

2.03

mmol/l

0.09

193

Degenerative diseases of the nervous system

232

786

2.14

24.13

1.2

1.99

2.34

mmol/l

5.32

215

718

Other viral diseases

241

1180

2.05

23.96

1.2

1.3

1.96

1.95

mmol/l

0.06

227

1102

Retention of urine

233

901

2.10

23.91

1.4

1.2

2.15

2.23

mmol/l

0.47

209

838

External causes of morbidity and mortality

417

1176

1.78

23.79

1.4

1.2

2.04

2.12

mmol/l

0.51

385

1098

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

682

2839

1.55

23.74

1.3

1.2

2.00

2.12

mmol/l

1.79

633

2632

Neoplasms

536

1706

1.65

23.67

1.3

1.2

2.09

1.90

mmol/l

2.71

502

1584

Mycoses

217

1031

2.12

23.64

1.3

2.43

2.07

mmol/l

1.14

197

967

Speech and linguistic disorders, excluding more controls

187

3.76

23.58

1.4

1.2

1.94

1.81

mmol/l

0.54

174

Osteopathies and chondropathies

386

2026

1.75

23.29

1.2

1.3

2.07

2.14

mmol/l

0.58

350

1884

Hypothyroidism, drug reimbursement

180

3.48

23.29

1.3

1.1

2.20

1.79

mmol/l

1.62

170

Dissociative [conversion] disorders

102

5.02

23.29

1.1

1.94

1.97

mmol/l

0.05

Non-selective monoamine reuptake inhibitors

235

1107

2.05

23.24

1.3

1.2

2.08

2.20

mmol/l

0.83

217

1032

Diseases of the respiratory system

390

1086

1.81

23.20

1.3

1.2

2.12

2.08

mmol/l

0.16

362

1016

402

2086

1.73

23.18

1.2

1.3

2.14

2.09

mmol/l

0.29

375

1942

Other general symptoms and signs

5.14

23.04

1.1

1.4

1.67

2.03

mmol/l

1.37

Other systemic involvement of connective tissue

203

954

2.14

22.77

1.2

1.3

2.01

2.07

mmol/l

0.28

187

881

Tick-borne viral encephalitis

34.21

22.68

1.2

1.4

2.15

1.87

mmol/l

—

Alcohol use disorder, Swedish definition

377

1972

1.75

22.59

1.2

1.3

2.18

2.10

mmol/l

0.51

348

1838

417

2142

1.70

22.58

1.2

1.3

2.15

2.09

mmol/l

0.38

387

1995

Other symptoms and signs involving the urinary system

100

339

2.99

22.53

1.4

1.3

2.08

2.09

mmol/l

0.02

318

Urinary track infection

398

1126

1.78

22.49

1.4

1.2

2.01

2.02

mmol/l

0.06

376

1041

Acute bronchitis

284

1480

1.89

22.44

1.2

1.3

1.91

2.06

mmol/l

1.91

261

1373

Transport accidents

316

1433

1.84

22.41

1.2

1.3

1.96

2.12

mmol/l

1.58

293

1344

Disorders of lipoprotein metabolism and other lipidaemias

508

1892

1.64

22.36

1.3

2.22

2.13

mmol/l

0.53

466

1755

Lung diseases due to external agents

109

389

2.83

22.33

1.7

1.3

2.43

2.19

mmol/l

0.76

364

Nutritional anaemias

332

1772

1.79

22.06

1.2

1.3

2.17

2.15

mmol/l

0.09

303

1642

Arthropathies

610

1966

1.57

21.88

1.2

1.3

1.98

2.05

mmol/l

0.71

573

1820

Other acute lower respiratory infections

370

2041

1.73

21.85

1.2

1.3

1.96

2.08

mmol/l

1.12

342

1900

Other extrapyramidal and movement disorders in other diseases

184

847

2.19

21.79

1.3

1.96

2.14

mmol/l

1.59

171

795

Mental and behavioural disorders due to alcohol

351

1914

1.75

21.61

1.2

1.3

2.17

2.09

mmol/l

0.48

325

1791

Other strabismus

176

796

2.22

21.56

1.3

1.2

1.86

1.97

mmol/l

0.99

158

747

Other and unspecified nerve root and plexus disorders, also in other diseases

160

699

2.31

21.51

1.2

1.3

1.86

2.09

mmol/l

1.96

143

659

Other and unspecified iron deficiency

242

1241

1.96

21.27

1.2

1.3

2.10

2.11

mmol/l

0.04

219

1157

Iron deficiency anaemia

291

1556

1.84

21.24

1.2

1.3

2.13

2.12

mmol/l

0.03

264

1449

Undetermined asthma, excluding more controls

334

2.93

21.19

1.3

1.2

2.04

2.05

mmol/l

0.00

317

Undetermined asthma

335

2.92

21.08

1.3

1.2

2.04

2.05

mmol/l

0.00

317

Emotional disorders starting during childhood or adolecense, excluding more controls

4.78

21.03

1.4

1.1

1.73

1.69

mmol/l

0.10

Other viral diseases, including avohilmo

289

1563

1.84

21.03

1.2

1.3

1.92

1.97

mmol/l

0.33

272

1466

N06DA Anticholinesterases

213

796

2.08

20.99

1.2

2.15

2.31

mmol/l

0.62

198

728

Use of anticholinesterases

213

796

2.08

20.99

1.2

2.15

2.31

mmol/l

0.62

198

728

Type 2 diabetes, wide definition

509

2005

1.61

20.93

1.3

2.42

2.10

mmol/l

3.41

467

1861

Use of hypnotics and sedatives

701

2680

1.50

20.83

1.3

2.07

2.11

mmol/l

0.37

648

2496

Other diseases of intestines

705

2632

1.50

20.66

1.3

2.00

2.09

mmol/l

1.03

663

2446

Other disorders of eye and adnexa

126

505

2.52

20.57

1.3

1.88

2.06

mmol/l

1.25

116

473

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

355

1996

1.72

20.54

1.2

1.3

1.96

2.17

mmol/l

3.11

332

1864

323

1823

1.77

20.51

1.2

1.3

2.02

mmol/l

0.01

302

1702

Mental and behavioural disorders due to alcohol, excluding acute intoxication

303

1681

1.80

20.35

1.2

1.3

2.20

2.12

mmol/l

0.48

278

1582

Open wound of head

357

1963

1.72

20.28

1.2

2.03

2.12

mmol/l

0.96

333

1829

Inflammatory diseases of female pelvic organs

424

1753

1.66

20.28

1.3

1.92

2.06

mmol/l

2.25

378

1639

Leisure time condition

149

649

2.32

20.23

1.6

1.3

1.91

2.06

mmol/l

1.32

136

604

Vocal cord dysfunction

293

2.91

20.13

1.3

1.2

1.94

2.05

mmol/l

0.44

277

Other shoulder lesions

265

3.13

20.10

1.3

1.4

1.89

2.12

mmol/l

1.56

248

Thrombocytopenia, unspecified

220

3.37

20.10

1.6

1.3

2.46

2.18

mmol/l

0.39

206

Other bacterial intestinal infections

135

565

2.41

20.06

1.3

2.05

2.16

mmol/l

0.60

124

523

All chronic kidney diseases

344

1585

1.74

19.93

1.2

2.33

2.10

mmol/l

1.23

321

1470

Meningitis, viral

36.05

19.87

1.4

1.1

2.57

1.66

mmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

275

926

1.88

19.67

1.2

2.14

1.90

mmol/l

2.50

259

864

Finngen Rheumatological endpoints

634

2386

1.51

19.67

1.2

1.3

2.05

2.06

mmol/l

0.06

590

2221

Injury, poisoning and certain other consequences of external causes

326

906

1.81

19.65

1.3

1.2

2.04

2.05

mmol/l

0.04

298

838

Pure hypercholesterolaemia

446

1743

1.63

19.54

1.3

2.18

2.15

mmol/l

0.20

414

1620

Alcohol use disorder, ICD-based

280

1552

1.81

19.50

1.2

1.3

2.20

2.08

mmol/l

0.75

256

1464

Other and unspecified disorders of skin and subcutaneous tissue

176

3.64

19.49

1.2

1.3

1.84

2.20

mmol/l

1.90

164

Sensorineural hearing loss

461

1913

1.61

19.49

1.3

2.23

2.17

mmol/l

0.38

426

1782

Hypokalaemia

324

2.87

19.39

1.7

1.2

2.43

2.16

mmol/l

0.72

303

Disorders of mineral metabolism

237

3.21

19.12

1.3

2.21

2.15

mmol/l

0.11

224

Substance use, excluding alcohol

159

729

2.20

19.10

1.3

2.20

2.00

mmol/l

1.07

145

684

Chronic laryngitis and laryngotracheitis

114

452

2.55

19.07

1.3

1.96

2.16

mmol/l

1.25

109

427

Chronic apical periodontitis

724

2782

1.46

19.07

1.2

1.3

2.14

2.07

mmol/l

0.56

668

2582

Asthma-related infections

402

2412

1.63

19.01

1.3

2.06

2.10

mmol/l

0.20

373

2239

Asthma, hospital admission 2, infections

402

2412

1.63

19.01

1.3

2.06

2.10

mmol/l

0.20

373

2239

Polyuria

158

724

2.20

19.00

1.2

2.07

2.22

mmol/l

0.77

148

673

Injuries to the thorax

303

1731

1.76

18.99

1.3

2.06

2.13

mmol/l

0.40

272

1609

Post-traumatic stress disorder

275

3.02

18.90

1.3

1.2

1.85

1.86

mmol/l

0.03

258

Missing teeth due to accident, extraction or parodontitis

396

2168

1.64

18.79

1.4

1.3

2.19

2.18

mmol/l

0.07

355

2020

Genitourinary diseases

360

1047

1.73

18.71

1.3

1.2

1.96

2.07

mmol/l

1.13

340

971

Special screening examination for infectious and parasitic diseases

158

517

2.24

18.71

1.2

1.72

2.11

mmol/l

3.86

146

486

Heart failure, not strict

457

1930

1.60

18.65

1.4

1.3

2.30

2.16

mmol/l

1.18

423

1792

Diseases of arteries, arterioles and capillaries (FINNGEN)

147

439

2.32

18.65

1.3

1.2

2.39

2.00

mmol/l

2.05

136

409

Hypothyreosis and Thyroxine purchase for inclusion criteria

591

2576

1.51

18.57

1.3

2.05

2.09

mmol/l

0.39

540

2399

Infections of the skin and subcutaneous tissue

400

2439

1.62

18.44

1.3

2.03

2.07

mmol/l

0.29

374

2265

Hypothyroidism, other/unspecified

567

2464

1.52

18.41

1.3

1.2

2.06

2.09

mmol/l

0.24

517

2293

Erysipelas

324

1632

1.72

18.34

1.2

1.3

2.31

2.07

mmol/l

2.12

298

1517

Generalized anxiety disorder

134

582

2.32

18.28

1.1

1.2

1.75

1.92

mmol/l

2.73

128

543

Personality disorders

210

1087

1.95

18.19

1.2

1.3

1.88

1.96

mmol/l

0.67

186

1021

Cough

265

1373

1.81

18.17

1.3

2.04

2.16

mmol/l

0.75

244

1275

Disorders of the thyroid gland

603

2627

1.49

18.10

1.3

1.2

2.06

2.09

mmol/l

0.19

552

2450

Nonorganic sleeping disorders, excluding more controls

143

643

2.24

18.03

1.2

1.75

1.98

mmol/l

3.07

132

608

Polyarthropathies

430

1723

1.61

17.95

1.2

1.3

2.24

2.09

mmol/l

0.85

403

1592

Urticaria and erythema

263

1468

1.80

17.94

1.2

1.3

2.15

2.00

mmol/l

0.58

236

1375

Other disorders of ear

577

2491

1.50

17.78

1.3

2.12

mmol/l

0.05

537

2322

Conductive and sensorineural hearing loss

481

2054

1.56

17.75

1.2

1.3

2.22

2.16

mmol/l

0.39

442

1911

Follow-up examination after treatment for conditions other than malignant neoplasms

238

840

1.89

17.72

1.2

1.90

2.16

mmol/l

3.68

220

780

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

240

1309

1.85

17.70

1.4

1.3

2.22

2.05

mmol/l

1.02

222

1220

Hyperlipidaemia, other/unspecified

231

1113

1.87

17.63

1.2

1.3

2.14

2.23

mmol/l

0.59

213

1029

Insulin, intermediate and long-acting

348

2032

1.66

17.62

1.3

2.49

2.08

mmol/l

3.38

322

1895

Unspecified mental disorder

279

1594

1.76

17.58

1.2

1.3

2.08

2.03

mmol/l

0.23

258

1494

Ocular pain

276

2.94

17.58

1.2

1.3

1.82

2.05

mmol/l

1.26

254

Poisoning by medicine

170

827

2.07

17.57

1.2

1.3

1.98

1.95

mmol/l

0.17

154

776

Dementia in Alzheimer disease

102

327

2.63

17.56

1.2

2.02

2.31

mmol/l

2.64

291

Fibromyalgia

276

2.93

17.56

1.3

1.5

1.94

2.05

mmol/l

0.22

260

Candidiasis, including avohilmo

223

1194

1.88

17.45

1.2

1.3

2.13

2.02

mmol/l

0.74

199

1121

Spinal stenosis

293

1235

1.76

17.44

1.3

2.18

2.29

mmol/l

0.75

271

1152

Internal derangement of knee

252

1387

1.81

17.41

1.3

1.96

2.11

mmol/l

1.56

231

1289

Diseases of pulp and periapical tissues, including avohilmo

661

2338

1.47

17.36

1.2

1.3

2.06

2.07

mmol/l

0.10

611

2177

Polycystic ovarian syndrome, consortium definition

464

1696

1.57

17.36

1.4

1.2

2.10

2.01

mmol/l

0.74

434

1574

Other mental disorders due to brain damage and dysfunction and to physical disease

300

2.83

17.30

1.3

1.2

2.09

2.24

mmol/l

0.50

275

Kela-code for severe mental illness

252

1407

1.80

17.22

1.2

1.3

2.04

mmol/l

0.02

232

1320

Dermatitis

409

2535

1.58

17.19

1.3

2.10

2.11

mmol/l

0.06

381

2350

Giant cell arteritis

4.55

17.10

1.3

1.2

1.93

2.15

mmol/l

1.03

Diseases of the skin and subcutaneous tissue

618

2103

1.48

16.85

1.3

1.2

2.07

2.08

mmol/l

0.02

584

1944

Injuries to the ankle and foot

485

2729

1.52

16.79

1.2

1.3

1.88

2.06

mmol/l

3.34

443

2547

Renal failure

289

1431

1.73

16.71

1.3

2.27

2.20

mmol/l

0.29

262

1335

Other bacterial intestinal infections, including avohilmo

160

776

2.08

16.68

1.3

2.03

2.12

mmol/l

0.63

146

728

Use of levodopa decarboxylase inhibitor

393

2.54

16.59

1.2

1.91

2.28

mmol/l

4.30

370

Poisoning by drugs, medicaments and biological substances

181

921

1.98

16.54

1.2

1.3

1.96

1.99

mmol/l

0.13

165

866

Hyperkinetic disorders, excluding more controls

359

2.57

16.53

1.1

1.2

1.68

1.77

mmol/l

0.66

336

Suicide or other Intentional self-harm

185

949

1.96

16.51

1.3

2.06

1.99

mmol/l

0.39

165

891

Mycoses, including avohilmo

598

3131

1.46

16.44

1.2

1.3

2.13

2.07

mmol/l

0.32

546

2918

Cardiac arrhythmias

358

1399

1.65

16.43

1.2

2.07

1.93

mmol/l

1.03

330

1319

Other and unspecified effects of external causes

205

1090

1.89

16.42

1.2

1.3

1.77

1.99

mmol/l

4.86

189

1024

Insulin, fast-acting

237

1318

1.81

16.40

1.3

2.37

2.05

mmol/l

2.86

216

1236

Insulin medication

381

1982

1.60

16.38

1.3

2.49

2.05

mmol/l

4.05

352

1845

Other specified/unspecified arthritis

182

931

1.97

16.36

1.2

1.3

2.14

2.12

mmol/l

0.03

175

862

Bacterial intestinal infections, IBD co-morbidities

131

593

2.23

16.32

1.3

2.06

2.14

mmol/l

0.46

120

552

Dementia in other diseases classified elsewhere

104

4.21

16.31

1.2

2.02

2.13

mmol/l

0.33

Herpesviral [herpes simplex] infections, including avohilmo

191

995

1.93

16.29

1.3

2.20

1.99

mmol/l

0.78

182

926

severe traumatic brain injury, does not include concussion

149

710

2.11

16.29

1.4

1.2

2.30

2.20

mmol/l

0.32

131

665

Other heart diseases

287

1075

1.74

16.28

1.4

1.2

2.20

1.87

mmol/l

2.70

267

1006

Dyspnoea

567

2787

1.47

16.27

1.3

2.01

2.13

mmol/l

1.45

521

2594

Insulin, combination of fast acting with intermediate-acting or long-acting

381

2178

1.59

16.25

1.3

2.49

2.07

mmol/l

3.79

352

2026

Infections with a predominantly sexual mode of transmission, including avohilmo

287

1542

1.71

16.21

1.2

1.3

1.83

1.94

mmol/l

1.32

267

1446

Disorders of adult personality and behaviour

214

1159

1.86

16.20

1.2

1.3

1.90

1.94

mmol/l

0.26

190

1088

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

135

623

2.19

16.07

1.2

1.3

2.04

1.93

mmol/l

0.71

120

583

Irregular menses

328

1492

1.66

15.97

1.3

1.2

2.01

1.95

mmol/l

0.28

301

1387

Coagulation defects, purpura and other haemorrhagic conditions

146

697

2.11

15.92

1.5

1.3

2.32

2.04

mmol/l

0.88

130

652

Other disorders of glucose regulation and pancreatic internal secretion

259

2.89

15.88

1.2

1.3

2.03

2.08

mmol/l

0.18

242

Zoster [herpes zoster], including avohilmo

325

1919

1.64

15.83

1.3

2.14

2.17

mmol/l

0.16

299

1769

Secondary hypertension

188

3.23

15.80

1.2

2.14

1.97

mmol/l

0.33

181

Other problems related to primary support group, including family circumstances

102

409

2.45

15.72

1.6

1.2

1.84

1.86

mmol/l

0.06

381

Schizophrenia, schizotypal and delusional disorders

221

1221

1.82

15.70

1.2

1.3

2.15

2.02

mmol/l

0.56

201

1143

Dermatitis and eczema

710

2987

1.41

15.66

1.3

1.2

2.12

2.08

mmol/l

0.22

665

2766

Encephalopathy

15.65

15.58

1.2

1.1

1.89

1.91

mmol/l

0.03

Benign paroxysmal vertigo

194

1032

1.89

15.55

1.2

1.3

1.94

2.15

mmol/l

2.27

186

962

Other arthritis (FG)

207

1124

1.85

15.55

1.2

1.3

2.23

2.12

mmol/l

0.28

200

1046

Diseases of liver

226

1263

1.80

15.46

1.3

2.36

2.09

mmol/l

1.32

206

1184

107

458

2.36

15.25

1.7

1.2

1.97

2.06

mmol/l

0.42

100

429

Any event in cancer register

567

2268

1.46

15.25

1.4

1.2

2.18

2.02

mmol/l

2.14

535

2115

Pain and other conditions associated with female genital organs and menstrual cycle

161

669

2.02

15.24

1.2

1.88

1.98

mmol/l

0.56

147

622

Schizophrenia or delusion

219

1218

1.81

15.24

1.2

1.3

2.15

2.03

mmol/l

0.54

199

1141

Candidiasis

111

484

2.31

15.17

1.2

1.3

2.29

2.10

mmol/l

0.66

101

452

Insulin, fast-acting or short human

238

1363

1.75

14.95

1.3

2.37

2.07

mmol/l

2.83

217

1280

Glomerular diseases

128

596

2.17

14.93

1.1

1.3

2.18

2.16

mmol/l

0.05

117

560

Hypoglycaemia, other or unspecified

205

3.07

14.75

1.2

1.3

2.02

2.04

mmol/l

0.05

193

Heterophoria

243

2.87

14.67

1.4

1.2

1.88

1.96

mmol/l

0.32

224

Disorders of psychological development

102

401

2.38

14.66

1.4

1.3

1.82

1.77

mmol/l

0.20

371

Other infectious diseases

211

3.02

14.66

1.3

2.08

2.15

mmol/l

0.14

198

Problems related to lifestyle

328

2.59

14.62

1.4

1.2

2.18

2.10

mmol/l

0.31

304

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

150

3.43

14.61

1.2

2.01

2.16

mmol/l

0.54

138

Irritable bowel syndrome

194

1058

1.84

14.43

1.2

1.3

1.90

2.06

mmol/l

1.84

174

985

Osteoporosis

163

768

1.96

14.40

1.2

1.3

2.19

2.22

mmol/l

0.10

145

706

Secondary parkinsonism

5.11

14.37

1.2

2.12

1.95

mmol/l

0.48

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

257

2.79

14.35

1.2

2.02

2.04

mmol/l

0.03

237

Other disorders of skin and subcutaneous tissue, not elsewhere classified

104

452

2.32

14.35

1.1

1.3

2.04

2.16

mmol/l

0.43

424

Vitamin deficiency

129

3.62

14.24

1.2

1.4

2.06

2.00

mmol/l

0.19

124

Vitamin deficiency, wide

129

3.62

14.24

1.2

1.4

2.06

2.00

mmol/l

0.19

124

Shoulder lesions

452

1801

1.51

14.19

1.3

2.06

2.21

mmol/l

1.98

418

1667

Acute renal failure

143

708

2.03

14.19

1.3

1.2

2.34

2.21

mmol/l

0.41

128

662

Other disorders of skin and subcutaneous tissue

444

2515

1.49

14.16

1.3

2.19

2.13

mmol/l

0.35

405

2342

Other infectious diseases, including avohilmo

265

2.75

14.11

1.2

1.3

2.06

2.16

mmol/l

0.23

249

Other and unspecified tonsillitis

227

1076

1.76

14.09

1.2

1.85

1.97

mmol/l

0.83

209

1013

Specific personality disorders

176

939

1.89

14.05

1.2

1.3

1.85

1.95

mmol/l

0.82

155

878

Other viral diseases, not elsewhere classified

141

695

2.04

14.04

1.2

1.3

1.97

2.00

mmol/l

0.13

133

646

Other and unspecified dermatitis

334

2129

1.57

13.89

1.3

2.10

2.11

mmol/l

0.06

312

1975

Functional dyspepsia

180

971

1.86

13.88

1.2

1.3

2.00

2.09

mmol/l

0.52

172

909

Secondary parkinsonism+Parkinsonism in other disease

4.94

13.85

1.2

1.1

2.12

1.95

mmol/l

0.48

Diabetic maculopathy, excluding more controls

350

2.48

13.77

1.2

1.3

2.34

2.02

mmol/l

1.61

333

Enterocolitis due to Clostridium difficile

309

2.58

13.73

1.3

2.04

2.19

mmol/l

0.65

287

Dental pulpitis, including avohilmo

592

2683

1.42

13.67

1.2

1.3

1.99

2.07

mmol/l

0.85

548

2510

Erysipelas, including avohilmo

405

1988

1.51

13.48

1.3

2.25

2.05

mmol/l

2.06

377

1842

Other acute disseminated demyelination

10.24

13.43

1.1

1.3

2.15

1.89

mmol/l

0.25

Panic disorder

113

523

2.18

13.43

1.2

1.91

1.92

mmol/l

0.03

106

488

Diabetic retinopathy, strict definition

117

484

2.16

13.38

1.2

2.27

2.29

mmol/l

0.06

105

443

Exposure to other specified factors

517

3115

1.43

13.13

1.3

1.92

2.10

mmol/l

3.77

478

2902

Urticaria

211

1215

1.75

13.12

1.3

2.05

1.98

mmol/l

0.21

191

1142

Benign neoplasms

608

2359

1.41

13.07

1.3

2.08

2.03

mmol/l

0.41

569

2197

Obesity related asthma

229

1353

1.70

12.98

1.2

1.3

2.13

2.10

mmol/l

0.11

215

1261

Injuries to the abdomen, lower back, lumbar spine and pelvis

257

1541

1.65

12.98

1.2

1.3

2.08

mmol/l

0.00

232

1437

Emotional disorders starting during childhood or adolescence

151

3.26

12.92

1.4

1.2

1.71

1.68

mmol/l

0.09

139

Speech and linguistic disorders

293

2.55

12.90

1.4

1.3

1.94

1.74

mmol/l

1.08

269

Exclusions for E4_PCOS_CONSORTIUM

457

1944

1.47

12.89

1.2

1.3

2.03

2.01

mmol/l

0.09

421

1800

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

166

774

1.88

12.89

1.2

1.3

1.73

1.75

mmol/l

0.13

152

726

Behavioural syndromes associated with physiological disturbances and physical factors

587

2845

1.40

12.79

1.2

1.3

1.90

2.13

mmol/l

5.37

539

2642

Care involving dialysis

212

2.86

12.74

1.3

1.2

2.01

2.05

mmol/l

0.14

198

Other and unspecified urticaria

143

738

1.95

12.68

1.3

2.05

1.98

mmol/l

0.17

130

690

Hypotension

109

510

2.15

12.62

1.3

1.2

2.07

2.23

mmol/l

0.97

475

Abnormal findings on examination of blood, without diagnosis

284

1609

1.60

12.62

1.2

1.3

2.25

2.15

mmol/l

0.53

264

1502

Purpura and other haemorrhagic conditions

101

459

2.22

12.60

1.4

1.3

2.38

2.11

mmol/l

0.55

429

Acute pharyngitis

115

546

2.10

12.48

1.3

1.2

1.92

1.95

mmol/l

0.08

105

514

Noninfective enteritis and colitis

296

1881

1.58

12.47

1.3

2.02

2.06

mmol/l

0.33

277

1757

Use of donepezil

112

506

2.12

12.45

1.2

2.04

2.28

mmol/l

0.82

102

461

Disorders of choroid and retina

470

2279

1.45

12.45

1.3

2.21

2.16

mmol/l

0.36

433

2116

Convergent concomitant strabismus

167

3.10

12.40

1.1

1.3

1.87

mmol/l

0.01

155

Other CVD

121

594

2.05

12.35

1.3

1.2

2.06

2.21

mmol/l

0.90

108

556

Glomerular disorders in diseases classified elsewhere

381

2.33

12.34

1.1

1.3

2.24

2.15

mmol/l

0.22

360

Chronic sinusitis

264

1638

1.62

12.31

1.2

1.3

2.00

2.14

mmol/l

1.12

239

1535

Type 1 diabetes

168

922

1.83

12.27

1.3

2.35

1.95

mmol/l

1.36

153

870

Decubitus ulcer and pressure area

158

3.14

12.22

1.7

1.2

2.41

2.24

mmol/l

0.27

146

Dental operations

332

1090

1.57

12.22

1.3

1.2

2.11

2.22

mmol/l

0.66

312

1003

Chronic kidney disease

179

964

1.79

12.21

1.2

2.28

2.23

mmol/l

0.17

163

899

Infections with a predominantly sexual mode of transmission

214

1261

1.70

12.18

1.3

1.85

1.95

mmol/l

0.99

199

1188

Disorders of sclera, cornea, iris and ciliary body

340

2246

1.52

12.12

1.2

1.3

2.14

2.08

mmol/l

0.31

318

2083

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

330

2.42

12.02

1.9

1.3

2.10

2.18

mmol/l

0.20

309

Injuries to the wrist and hand

631

3064

1.37

12.02

1.3

1.95

2.11

mmol/l

2.80

586

2849

Other heart diseases, wide

577

2515

1.39

11.99

1.3

2.10

2.05

mmol/l

0.34

536

2344

Use of rivastigmine

386

2.29

11.87

1.2

2.36

2.23

mmol/l

0.22

351

Other noninfective gastroenteritis and colitis

164

904

1.82

11.86

1.3

2.10

2.05

mmol/l

0.22

148

846

Other diseases of upper respiratory tract

645

2459

1.37

11.83

1.2

1.3

1.96

2.15

mmol/l

3.87

590

2286

Mental and behavioural disorders due to opioids

121

3.45

11.83

1.3

1.5

2.24

1.84

mmol/l

0.64

114

Coxibs

161

445

1.91

11.74

1.2

1.3

1.99

2.17

mmol/l

0.77

150

412

Excessive, frequent and irregular menstruation

245

787

1.67

11.59

1.4

1.2

2.04

2.00

mmol/l

0.18

230

732

Other nutritional deficiencies

422

2675

1.44

11.58

1.2

1.3

2.16

2.05

mmol/l

0.81

386

2506

Diabetic retinopathy, excluding more controls

158

469

1.90

11.51

1.3

2.19

2.23

mmol/l

0.23

144

429

Fracture of rib(s), sternum and thoracic spine

184

1060

1.74

11.49

1.4

1.2

1.98

2.17

mmol/l

1.99

168

993

Alzheimer disease, including avohilmo

196

782

1.74

11.45

1.2

2.06

2.34

mmol/l

2.47

183

713

Other diseases of the respiratory system

126

646

1.96

11.44

1.5

1.2

2.15

2.20

mmol/l

0.19

114

604

Other respiratory disorders and diseases

126

646

1.96

11.44

1.5

1.2

2.15

2.20

mmol/l

0.19

114

604

Caries of dentine, including avohilmo

447

1577

1.45

11.42

1.3

2.11

2.13

mmol/l

0.14

421

1463

Inflammatory disease of uterus

102

485

2.12

11.40

1.2

1.3

1.86

1.93

mmol/l

0.36

460

Disorders of muscles

296

2.45

11.35

1.1

1.4

1.85

2.08

mmol/l

1.80

276

All influenza (not pneumonia)

461

2.14

11.25

1.2

1.3

2.11

2.05

mmol/l

0.14

431

Temporomandibular joint disorders, including avohilmo

297

1878

1.54

11.17

1.2

1.3

1.92

1.99

mmol/l

0.54

270

1753

Inflammatory diseases of prostate (prostatitis)

360

2.30

11.16

1.3

1.93

2.40

mmol/l

3.10

337

Sleep disorders

558

2800

1.38

11.10

1.2

1.3

1.90

2.12

mmol/l

4.72

511

2601

Diseases of male genital organs

292

932

1.58

11.10

1.2

1.99

2.17

mmol/l

1.75

273

863

Emotional disorders and disorders of social functioning with onset specific to childhood

164

2.96

11.04

1.4

1.2

1.72

1.70

mmol/l

0.07

150

Superficial injury of lower leg

172

984

1.76

11.04

1.2

1.3

1.95

2.01

mmol/l

0.28

159

921

Dental caries, including avohilmo

409

1435

1.46

10.88

1.3

2.15

mmol/l

0.02

384

1329

Abnormal findings on diagnostic imaging of lung

265

1607

1.57

10.86

1.3

2.22

2.24

mmol/l

0.08

249

1493

Other diseases of pleura

250

1371

1.59

10.76

1.3

2.21

2.22

mmol/l

0.03

229

1275

Hypothyroidism, strict autoimmune, 3 medication purchases required

497

2399

1.39

10.75

1.3

2.01

2.10

mmol/l

0.98

452

2236

Injuries to the knee and lower leg

720

2947

1.32

10.68

1.2

1.3

2.02

2.10

mmol/l

0.95

678

2728

Other viral diseases, not elsewhere classified, including avohilmo

185

1085

1.70

10.63

1.2

1.3

1.90

1.97

mmol/l

0.41

175

1009

Dystonia

167

2.91

10.56

1.2

1.4

1.70

2.14

mmol/l

2.95

158

Other retinal disorders

362

1880

1.47

10.52

1.3

2.18

2.19

mmol/l

0.05

333

1744

Early onset COPD, excluding more controls

101

493

2.06

10.51

1.4

1.2

2.25

2.19

mmol/l

0.14

470

Menorrhagia

208

689

1.69

10.48

1.5

1.3

2.03

2.06

mmol/l

0.18

192

638

Familial hypercholesterolemia

390

2.19

10.43

1.3

1.2

2.20

2.24

mmol/l

0.12

370

Abnormal findings on diagnostic imaging of other body structures

463

2.09

10.38

1.3

2.08

2.19

mmol/l

0.35

431

Emotionally unstable personality disorder

484

2.06

10.34

1.1

1.3

1.88

1.86

mmol/l

0.07

451

Sequelae of injuries of head

164

2.91

10.30

1.7

1.4

2.01

2.06

mmol/l

0.15

156

Superficial injury of abdomen, lower back and pelvis

112

573

1.97

10.29

1.2

1.3

2.11

2.02

mmol/l

0.22

106

532

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

191

1134

1.67

10.27

1.4

1.2

1.78

1.94

mmol/l

2.19

175

1061

Misadventures to patients during surgical and medical care

446

2.10

10.21

1.4

1.2

2.28

2.05

mmol/l

0.72

414

Obesity due to excess calories

302

2023

1.50

10.18

1.2

1.3

2.18

2.01

mmol/l

0.98

283

1894

Other and unspecified drugs and medicaments

275

2.43

10.17

1.2

1.3

2.03

2.05

mmol/l

0.04

253

Amblyopia ex anopsia

113

3.32

10.15

1.5

1.4

1.86

1.82

mmol/l

0.13

106

Diabetic neuropathy

356

2.23

10.04

1.3

1.2

2.38

2.36

mmol/l

0.05

329

Chronic lower respiratory diseases

732

2951

1.31

10.03

1.3

2.01

2.10

mmol/l

0.90

677

2746

Malignant neoplasm, wide definition

505

2135

1.38

10.02

1.4

1.3

2.21

2.06

mmol/l

1.54

476

1985

Cellulitis

144

806

1.80

10.02

1.3

2.05

2.06

mmol/l

0.03

135

752

Asthma-related pneumonia or sepsis

213

1321

1.61

9.98

1.3

2.14

2.11

mmol/l

0.09

194

1222

Asthma, hospital admissions 3, pneumonia

213

1321

1.61

9.98

1.3

2.14

2.11

mmol/l

0.09

194

1222

Malignant neoplasm, including Hilmo

504

2135

1.38

9.92

1.4

1.3

2.20

2.06

mmol/l

1.48

475

1984

Disorders of lens

368

1574

1.45

9.91

1.3

2.20

mmol/l

0.02

349

1461

Alzheimer disease

165

678

1.75

9.88

1.2

2.02

2.35

mmol/l

4.04

154

614

Asthma-related pneumonia

212

1318

1.61

9.84

1.3

2.13

2.12

mmol/l

0.05

193

1221

Diabetic maculopathy

370

2.16

9.83

1.2

2.34

2.25

mmol/l

0.29

337

Disorders of skin appendages

313

2117

1.48

9.79

1.3

1.99

2.03

mmol/l

0.25

292

1974

Malignant neoplasm

490

2083

1.38

9.79

1.3

2.23

2.07

mmol/l

1.68

462

1936

Superficial injury of head

144

811

1.78

9.77

1.1

1.3

2.00

2.06

mmol/l

0.22

132

761

Other disorders of bone

129

704

1.84

9.77

1.2

1.3

1.94

2.04

mmol/l

0.49

121

664

Diseases of middle ear and mastoid

364

2070

1.44

9.76

1.2

1.3

2.07

1.99

mmol/l

0.36

339

1933

Tetraplegia

11.98

9.70

4.3

1.1

1.88

1.70

mmol/l

0.32

Malignant neoplasm

489

2082

1.38

9.68

1.3

2.23

2.08

mmol/l

1.68

461

1935

Type 1 diabetes, wide definition, subgroup 1

136

757

1.80

9.62

1.2

1.3

2.15

1.95

mmol/l

1.95

122

719

Diseases of pulp and periapical tissues and dental caries

362

1275

1.46

9.60

1.3

2.13

2.14

mmol/l

0.07

338

1185

Transplanted organ and tissue status

314

2.28

9.58

1.3

2.42

2.08

mmol/l

0.66

300

Gastroduodenal ulcer

139

780

1.78

9.49

1.3

2.27

2.29

mmol/l

0.05

126

721

Fracture of skull and facial bones

131

725

1.82

9.49

1.4

1.2

2.20

2.06

mmol/l

0.42

114

687

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

125

684

1.84

9.40

1.2

1.3

1.84

1.94

mmol/l

0.81

108

650

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

249

1609

1.53

9.38

1.2

1.3

1.80

1.97

mmol/l

2.46

225

1513

Extracorporeal dialysis

185

2.68

9.30

1.3

1.2

2.01

2.13

mmol/l

0.43

174

Asthma (diagnoses ohter than nonallergic)

523

3151

1.34

9.28

1.3

1.2

2.04

2.08

mmol/l

0.21

482

2935

Pulmonary heart disease

163

967

1.69

9.26

1.4

1.3

2.24

2.16

mmol/l

0.36

154

901

Insomnia

540

2808

1.34

9.25

1.2

1.3

1.91

2.12

mmol/l

4.19

493

2614

Injuries to the shoulder and upper arm

505

2890

1.35

9.24

1.3

2.11

2.12

mmol/l

0.05

470

2683

Osteoporosis with pathological fracture (FG)

163

2.79

9.22

1.2

2.06

2.17

mmol/l

0.46

152

Pulmonary embolism

163

968

1.69

9.22

1.4

1.3

2.24

2.16

mmol/l

0.36

154

902

Asthma, including avohilmo

707

3008

1.30

9.17

1.2

1.3

2.00

2.10

mmol/l

1.09

655

2795

Diabetes mellitus

607

2656

1.32

9.17

1.3

2.27

2.01

mmol/l

5.15

554

2477

Abnormal spermatozoa

372

2.14

9.16

1.2

2.24

2.17

mmol/l

0.12

352

Unspecified haematuria

226

1178

1.57

9.15

1.2

1.3

2.37

2.19

mmol/l

0.71

211

1092

Brachial plexus disorders

308

2.26

9.13

1.2

1.3

1.95

1.90

mmol/l

0.15

286

Sequelae of external causes of morbidity and mortality

154

905

1.71

9.08

1.6

1.3

2.30

2.13

mmol/l

0.63

145

849

Alcohol dependence

154

905

1.71

9.08

1.2

1.3

2.03

2.10

mmol/l

0.47

141

851

Other condition

101

522

1.95

9.08

1.3

2.05

2.09

mmol/l

0.10

487

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

146

846

1.74

9.07

1.2

1.3

1.83

1.91

mmol/l

0.44

138

788

Rheumatism, unspecified

387

2.11

9.04

1.4

2.09

2.17

mmol/l

0.16

361

Pulmonary heart disease, diseases of pulmonary circulation

174

1058

1.65

9.01

1.4

1.3

2.22

2.18

mmol/l

0.18

165

986

Other diseases of anus and rectum

175

1062

1.65

8.99

1.3

2.16

2.22

mmol/l

0.25

163

979

Heart failure and antihypertensive medication

132

473

1.82

8.93

1.4

1.2

2.30

2.12

mmol/l

0.58

123

450

Dialysis, with operation codes

430

2.04

8.89

1.3

2.31

2.07

mmol/l

0.58

406

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

231

2.45

8.87

1.2

1.4

2.12

1.88

mmol/l

0.75

212

Conjunctivitis (acute, non atopic)

184

1135

1.62

8.86

1.2

1.3

1.95

2.02

mmol/l

0.34

176

1059

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

547

2440

1.33

8.78

1.2

1.3

2.32

2.04

mmol/l

4.90

501

2269

Hypermobility syndrome

174

2.68

8.72

1.3

2.23

1.89

mmol/l

0.41

161

Other predominantly sexually transmitted diseases, not elsewhere classified

121

672

1.81

8.72

1.2

1.3

1.90

1.92

mmol/l

0.07

114

625

DVT of lower extremities and pulmonary embolism

223

1446

1.54

8.65

1.3

2.25

2.19

mmol/l

0.31

210

1338

Venous thromboembolism

291

1926

1.46

8.64

1.3

2.27

2.19

mmol/l

0.40

274

1772

Other female pelvic inflammatory diseases

100

525

1.92

8.60

1.2

1.3

1.93

2.06

mmol/l

0.83

494

Type 1 diabetes, wide definition

139

806

1.73

8.60

1.2

1.3

2.19

1.95

mmol/l

1.98

125

763

Pain associated with micturition

395

2.07

8.59

1.4

1.3

1.95

2.12

mmol/l

0.97

366

Other diseases of hard tissues of teeth

312

1104

1.47

8.59

1.3

1.2

2.10

2.14

mmol/l

0.25

292

1025

Diseases of the digestive system

255

1699

1.49

8.57

1.3

2.17

2.14

mmol/l

0.12

232

1570

Covid-19 suspected case

140

816

1.72

8.54

1.2

1.3

1.84

1.96

mmol/l

1.31

133

760

Fenamates

289

2.06

8.52

1.6

1.3

2.24

2.21

mmol/l

0.06

271

Diabetes, varying definitions

600

2662

1.31

8.50

1.3

2.28

2.01

mmol/l

5.33

549

2481

Haemorrhage from respiratory passages

185

1022

1.61

8.49

1.3

2.29

2.22

mmol/l

0.21

177

948

Fentanyl

248

2.35

8.45

1.3

2.50

2.10

mmol/l

1.41

232

Other disorders of patella

110

600

1.84

8.41

1.2

1.4

1.97

2.02

mmol/l

0.18

103

557

Diabetes medication

611

2742

1.30

8.41

1.3

2.28

2.02

mmol/l

4.79

557

2555

Striking against or struck by other objects

213

1382

1.54

8.38

1.3

1.88

2.02

mmol/l

1.30

194

1296

Complications of internal orthopaedic prosthetic devices, implants and grafts

120

673

1.79

8.38

1.5

1.2

2.22

2.16

mmol/l

0.13

114

622

Nephropathy related operations

413

2.03

8.36

1.3

2.35

2.07

mmol/l

0.67

387

Deforming dorsopathies

155

934

1.67

8.34

1.2

1.3

2.11

2.18

mmol/l

0.22

135

879

Sub-endpoint used in defining T1D endpoints

169

1024

1.63

8.34

1.3

2.35

2.01

mmol/l

1.06

153

964

Injuries to the neck

152

914

1.67

8.28

1.2

1.80

2.01

mmol/l

2.70

139

857

Enthesopathies of lower limb, excluding foot

130

750

1.74

8.24

1.2

1.3

1.91

2.17

mmol/l

2.49

116

708

Hernia of abdominal wall, postoperative

501

1.91

8.22

1.2

1.88

2.04

mmol/l

1.44

470

Dentofacial anomalies [including malocclusion]

428

2470

1.36

8.22

1.2

1.3

1.91

2.05

mmol/l

2.03

397

2311

Diabetic nephropathy, excluding more controls

357

2.00

8.15

1.1

1.3

2.47

2.20

mmol/l

0.34

327

Adverse effects, not elsewhere classified

130

754

1.73

8.10

1.3

1.74

2.00

mmol/l

3.97

122

706

Carpal tunnel syndrome

330

2033

1.41

8.05

1.2

1.3

2.18

2.15

mmol/l

0.15

312

1886

Disorders of refraction and accommodation

173

1079

1.60

8.02

1.4

1.2

1.98

1.96

mmol/l

0.08

161

1016

Car occupant injured in other and unspecified transport accidents

124

713

1.75

7.98

1.2

1.3

2.00

1.97

mmol/l

0.12

117

666

Vasomotor and allergic rhinitis

225

1461

1.51

7.97

1.2

1.3

1.82

2.04

mmol/l

2.81

209

1374

Benign neoplasm of other and unspecified endocrine glands

441

1.96

7.97

1.3

2.11

2.16

mmol/l

0.12

411

Hyperplasia of prostate

187

657

1.61

7.95

1.2

2.01

2.27

mmol/l

2.36

173

609

Parkinson's disease, including avohilmo

469

1.93

7.95

1.2

1.93

2.25

mmol/l

3.74

441

Iridocyclitis

137

811

1.70

7.94

1.2

1.3

2.14

2.06

mmol/l

0.35

128

760

Chronic diseases of tonsils and adenoids

454

2133

1.34

7.92

1.2

1.3

1.88

2.11

mmol/l

4.42

416

1992

Unspecified/other endometriosis

314

2.14

7.89

1.3

1.60

1.94

mmol/l

4.85

292

Reimbursement for rheumatic diseases

317

2241

1.41

7.88

1.3

2.32

2.11

mmol/l

0.98

298

2080

Assault

492

1.90

7.86

1.2

1.3

1.86

1.93

mmol/l

0.41

463

Mouth breathing

222

1475

1.51

7.86

1.2

1.3

1.90

2.10

mmol/l

3.31

206

1389

Urolithiasis

176

1113

1.59

7.85

1.3

2.36

2.17

mmol/l

0.53

162

1039

Diabetes, insulin treatment (Kela reimbursement)

573

2628

1.30

7.78

1.2

1.3

2.32

2.07

mmol/l

4.41

526

2442

Superficial injury of wrist and hand

134

795

1.69

7.72

1.2

1.3

1.77

1.99

mmol/l

2.37

125

749

Acute alcohol intoxication

146

886

1.66

7.71

1.2

1.3

2.13

2.07

mmol/l

0.23

141

831

Solid cancers, including Hilmo

476

2087

1.33

7.66

1.4

1.3

2.20

2.08

mmol/l

1.22

450

1940

Gastric ulcer

527

1.85

7.56

1.3

2.26

2.23

mmol/l

0.08

489

Fracture of lumbar spine and pelvis

124

723

1.72

7.54

1.2

1.3

2.05

2.15

mmol/l

0.49

108

668

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

471

1.90

7.53

1.3

1.2

2.32

2.22

mmol/l

0.32

442

Anterior Iridocyclitis

123

718

1.72

7.53

1.2

1.3

2.19

2.07

mmol/l

0.50

114

673

Compression of brain

+∞

7.50

1.7

0.0

1.81

—

mmol/l

—

Parkinson's disease

451

1.92

7.48

1.2

1.93

2.24

mmol/l

3.51

425

Noninfectious colitis NAS

473

1.89

7.45

1.3

2.08

2.11

mmol/l

0.08

445

Nonorganic sleeping disorders

143

873

1.65

7.41

1.2

1.3

1.75

1.98

mmol/l

2.99

132

812

Necrosis of pulp, including avohilmo

350

2531

1.37

7.37

1.2

1.3

1.97

2.09

mmol/l

1.48

327

2355

Open wound of wrist and hand

267

1802

1.44

7.36

1.2

1.3

1.97

2.09

mmol/l

1.24

240

1685

Insulin, fast-acting (human)

482

1.88

7.36

1.2

1.3

2.22

2.00

mmol/l

1.02

452

Disorders of gallbladder, biliary tract and pancreas

556

2681

1.29

7.34

1.2

1.3

2.16

2.12

mmol/l

0.34

522

2492

Other arrhythmias

369

2025

1.36

7.27

1.2

1.3

1.98

2.10

mmol/l

1.49

335

1892

Acetic acid derivatives and related substances

141

431

1.70

7.25

1.2

1.3

2.03

2.18

mmol/l

0.70

132

398

Disturbance of activity and attention

501

1.84

7.21

1.1

1.3

1.69

1.75

mmol/l

0.35

465

Acute and subacute iridocyclitis

114

663

1.73

7.10

1.2

1.3

2.23

2.06

mmol/l

0.73

105

620

Abnormal weight loss

295

2.12

7.10

1.2

1.3

2.01

2.20

mmol/l

0.40

276

Fracture of foot, except ankle

152

953

1.60

7.08

1.3

1.96

1.99

mmol/l

0.18

137

899

Other abnormal uterine and vaginal bleeding

132

566

1.68

7.07

1.6

1.3

2.26

2.12

mmol/l

0.58

124

523

Methotrexate

432

1.91

7.06

1.3

1.4

2.67

2.07

mmol/l

0.85

405

Type 2 diabetes

558

2514

1.29

7.06

1.2

1.3

2.29

2.03

mmol/l

4.43

508

2345

Voice disturbances

152

956

1.60

7.00

1.2

1.3

1.97

2.10

mmol/l

0.77

141

892

Senile cataract

318

1389

1.39

6.98

1.3

2.22

mmol/l

0.01

302

1290

Acute suppurative otitis media

172

1036

1.55

6.96

1.3

2.03

1.89

mmol/l

0.53

161

966

Hyperkinetic disorders

542

1.79

6.95

1.1

1.3

1.68

1.75

mmol/l

0.51

502

Sequelae of inflammatory diseases of the central nervous system

18.03

6.87

2.9

1.2

4.45

1.66

mmol/l

—

Keratitis

207

1399

1.48

6.87

1.2

1.3

2.17

2.07

mmol/l

0.37

193

1309

Oter anti-inflammatory and antirheumatic agents, non-steroids

114

356

1.77

6.86

1.2

1.3

2.26

2.27

mmol/l

0.03

102

329

Use of pramipexole

120

715

1.69

6.86

1.3

2.11

2.18

mmol/l

0.27

106

669

Cutaneous abscess, furuncle and carbuncle

158

1008

1.57

6.86

1.3

2.08

2.02

mmol/l

0.32

148

945

Other disorders of eyelid

228

1480

1.46

6.84

1.3

2.28

2.23

mmol/l

0.15

209

1369

Postpartum care and examination

104

365

1.80

6.83

1.2

1.94

1.77

mmol/l

0.72

338

Congenital malformations, deformations and chromosomal abnormalities

347

2435

1.35

6.79

1.4

1.2

2.04

1.99

mmol/l

0.37

324

2270

Dislocation, sprain and strain of joints and ligaments at neck level

104

598

1.75

6.77

1.1

1.3

1.74

2.00

mmol/l

3.18

560

Trigeminal neuralgia

161

2.51

6.76

1.3

2.18

1.92

mmol/l

0.41

151

Calculus of kidney and ureter

161

1035

1.56

6.76

1.3

2.41

2.16

mmol/l

0.68

148

965

Weight loss

315

2.05

6.72

1.2

1.3

2.01

2.18

mmol/l

0.36

293

Mental and behavioural disorders due to tobacco

302

2.07

6.71

1.5

1.3

2.18

2.11

mmol/l

0.16

283

Allergic asthma (mode), excluding more controls

114

659

1.69

6.63

1.4

1.2

1.84

1.99

mmol/l

1.12

105

622

Disorders of conjunctiva

487

2929

1.29

6.62

1.2

1.3

1.94

2.10

mmol/l

2.33

450

2726

Superficial injury of shoulder and upper arm

414

1.90

6.61

1.1

1.3

2.08

2.06

mmol/l

0.04

384

Parkinson's disease, strict definition

414

1.90

6.60

1.2

1.95

2.26

mmol/l

3.16

391

Allergic asthma (mode)

114

660

1.69

6.60

1.4

1.2

1.84

1.99

mmol/l

1.17

105

624

Smoking dependency

304

2.06

6.60

1.5

1.3

2.18

2.17

mmol/l

0.02

285

Meralgia paraesthetica

2.99

6.56

1.0

1.5

2.06

1.95

mmol/l

0.27

Gout

137

729

1.62

6.56

1.2

1.3

2.26

2.19

mmol/l

0.26

128

673

Superficial injury of thorax

538

1.78

6.54

1.2

1.3

2.08

2.12

mmol/l

0.10

502

Restless leg syndrome

480

1.82

6.53

1.3

1.96

2.14

mmol/l

0.99

448

Paroxysmal tachycardia

114

560

1.70

6.51

1.3

1.2

2.11

1.93

mmol/l

0.83

105

521

Solid cancers

452

2031

1.31

6.49

1.3

2.22

2.09

mmol/l

1.26

425

1886

Obesity and other hyperalimentation

369

2612

1.33

6.46

1.2

1.3

2.17

2.04

mmol/l

0.78

345

2440

Excessive vomiting in pregnancy

294

2.06

6.41

1.3

1.2

1.97

1.94

mmol/l

0.05

275

Suppurative and unspecified otitis media

224

1377

1.44

6.40

1.3

1.2

1.98

1.93

mmol/l

0.19

209

1288

Cholecystectomy

384

2473

1.32

6.32

1.2

1.3

2.17

2.14

mmol/l

0.12

360

2287

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

168

1108

1.52

6.32

1.2

1.3

1.87

2.07

mmol/l

3.00

151

1035

Dislocation, sprain and strain of joints and ligaments of knee

358

2435

1.33

6.29

1.2

1.3

1.90

2.07

mmol/l

2.76

336

2263

Viral and other specified intestinal infections, including avohilmo

168

1066

1.52

6.28

1.4

1.2

1.90

1.94

mmol/l

0.21

159

1000

Other peripheral vertigo

283

2.07

6.27

1.3

1.90

2.28

mmol/l

2.60

264

Other diseases of stomach and duodenum

192

2.31

6.27

1.3

1.92

2.21

mmol/l

1.68

181

Injuries to the hip and thigh

257

1646

1.40

6.27

1.2

1.3

2.10

2.16

mmol/l

0.31

233

1525

Disorders of tooth development and eruption

102

482

1.73

6.23

1.3

1.2

1.86

2.02

mmol/l

1.07

457

Maltreatment syndromes

174

2.38

6.22

1.2

1.4

1.82

1.94

mmol/l

0.63

164

Obesity

366

2608

1.32

6.21

1.2

1.3

2.17

2.04

mmol/l

0.81

342

2437

Meniscus derangement

291

1401

1.38

6.19

1.3

2.00

2.17

mmol/l

2.43

266

1296

Hyperosmolality and hypernatraemia

5.85

6.18

1.1

2.17

1.89

mmol/l

0.67

Propionic acid derivatives

147

462

1.60

6.17

1.3

1.95

2.14

mmol/l

1.43

136

429

Sequelae of injuries, of poisoning and of other consequences of external causes

138

876

1.58

6.17

1.5

1.3

1.93

2.08

mmol/l

0.98

122

826

Other diseases of the digestive system

161

1059

1.53

6.14

1.3

2.26

2.20

mmol/l

0.22

147

979

Cervicocranial syndrome

306

2.01

6.11

1.1

1.3

1.88

2.13

mmol/l

1.27

290

Polymyalgia rheumatica

369

1.91

6.08

1.2

2.18

2.24

mmol/l

0.16

340

Rotator cuff syndrome

321

1637

1.35

6.04

1.2

1.3

2.02

2.24

mmol/l

3.22

296

1519

Diabetic retinopathy

184

764

1.50

6.01

1.3

2.29

2.36

mmol/l

0.32

169

703

Alzheimer’s disease, strict definition

115

563

1.65

5.98

1.2

1.99

2.33

mmol/l

3.43

106

506

Diseases of external ear

197

1358

1.46

5.98

1.2

1.3

2.04

2.11

mmol/l

0.29

179

1276

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

375

2608

1.31

5.97

1.4

1.2

2.03

mmol/l

0.02

348

2430

Diseases of peritoneum

317

1.97

5.91

1.5

1.3

2.11

2.22

mmol/l

0.32

297

Diseases of oral cavity, salivary glands and jaws

295

1108

1.37

5.84

1.3

1.2

2.11

2.14

mmol/l

0.15

275

1028

Pruritus

355

1.90

5.76

1.2

1.3

2.44

2.01

mmol/l

0.97

330

Acute and transient psychotic disorders

405

1.84

5.76

1.2

1.3

2.13

2.01

mmol/l

0.30

377

Other and unspecified mood [affective] disorders

219

2.16

5.75

1.1

1.3

2.24

1.87

mmol/l

0.48

205

Bacterial pneumonia, not elsewhere classified

186

1121

1.46

5.68

1.4

1.3

2.04

2.09

mmol/l

0.19

163

1048

Tonsillectomy and adenotomy

336

1765

1.33

5.62

1.2

1.3

1.84

1.94

mmol/l

1.01

308

1653

Anti-inflammatory and antirheumatic products, non-steroids

144

462

1.57

5.60

1.3

1.96

2.14

mmol/l

1.09

133

429

Deviated nasal septum

174

1188

1.47

5.55

1.2

1.3

1.97

2.18

mmol/l

2.19

163

1114

Rheumatoid arthritis

160

949

1.50

5.54

1.2

1.3

2.23

2.16

mmol/l

0.32

143

876

Childhood asthma (age<16)

284

1.88

5.46

1.2

1.84

1.87

mmol/l

0.08

269

Childhood asthma (age<16), excluding more controls

284

1.88

5.46

1.2

1.84

1.86

mmol/l

0.07

269

Other diseases of liver

105

645

1.64

5.44

1.4

1.3

2.16

2.11

mmol/l

0.19

604

Papulosquamous disorders

212

1510

1.41

5.42

1.2

1.3

2.08

2.12

mmol/l

0.18

195

1407

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

334

1973

1.32

5.40

1.3

1.2

2.09

2.04

mmol/l

0.21

318

1836

Chondropathies

540

1.69

5.39

1.3

1.93

2.07

mmol/l

0.92

506

Heartburn

342

1.88

5.39

1.2

2.12

mmol/l

0.01

317

Other fall from one level to another

133

866

1.54

5.37

1.8

1.2

2.04

2.02

mmol/l

0.08

125

809

Disorders of vitreous body and globe

265

1852

1.36

5.36

1.2

1.3

2.14

2.24

mmol/l

0.82

244

1720

Other gastritis (incl. Duodenitis)

114

720

1.59

5.28

1.2

1.3

2.03

2.17

mmol/l

0.56

104

677

GI-bleeding

156

1055

1.48

5.27

1.3

2.29

2.21

mmol/l

0.28

142

976

Tinnitus

127

824

1.55

5.24

1.2

1.3

1.98

2.12

mmol/l

0.48

116

783

Excessive earwax

339

2362

1.30

5.19

1.2

1.3

1.98

2.15

mmol/l

2.93

313

2190

Other (seronegative) rheumatoid arthritis, wide

600

1.64

5.17

1.2

1.3

2.27

2.16

mmol/l

0.37

563

Persistent mood disorders

103

639

1.62

5.15

1.2

1.3

2.16

2.06

mmol/l

0.25

599

Impingement syndrome of shoulder

122

789

1.55

5.11

1.4

1.3

2.28

2.24

mmol/l

0.13

107

733

Use of disulfiram, acamprosate or naltrexone

292

1.93

5.10

1.1

1.4

2.36

2.02

mmol/l

0.74

273

Bacterial pneumoniae

196

1219

1.41

5.10

1.4

1.3

2.10

2.08

mmol/l

0.08

171

1141

Cholecystitis

436

1.75

5.10

1.2

1.3

2.34

2.18

mmol/l

0.31

405

therapeutic use

3.11

5.08

1.3

1.2

2.29

1.93

mmol/l

0.53

Fall on and from stairs and steps

145

978

1.49

5.00

1.3

2.11

2.10

mmol/l

0.01

130

921

Conjunctivitis

433

2772

1.26

5.00

1.2

1.3

1.95

2.06

mmol/l

1.27

401

2584

Viral and other specified intestinal infections

121

766

1.55

4.99

1.4

1.2

1.87

1.94

mmol/l

0.40

115

716

Spondyloarthritis

598

1.63

4.98

1.3

2.15

2.04

mmol/l

0.41

559

Vitreous haemorrhage

330

1.86

4.98

1.2

1.3

2.15

2.20

mmol/l

0.15

305

Occlusion and stenosis of arteries, not leading to stroke

6.98

4.97

1.7

1.1

2.38

2.09

mmol/l

0.40

Disorders of vitreous body

256

1814

1.35

4.96

1.2

1.3

2.12

2.25

mmol/l

1.15

235

1684

Benign neoplasm: Colon, unspecified

126

827

1.53

4.96

1.2

1.3

2.14

2.24

mmol/l

0.40

120

774

Fall on same level involving ice and snow

312

2393

1.31

4.94

1.2

1.3

2.06

2.12

mmol/l

0.39

286

2228

Disorders of synovium and tendon

281

1799

1.33

4.91

1.2

1.3

1.92

2.17

mmol/l

4.95

262

1674

Dermatophytosis

479

1.70

4.90

1.4

1.3

2.75

2.12

mmol/l

0.70

448

Superficial injury of forearm

361

1.81

4.89

1.3

1.4

2.01

1.97

mmol/l

0.06

338

Nonsuppurative otitis media, including avohilmo

186

1138

1.42

4.89

1.1

1.3

2.16

1.94

mmol/l

0.76

175

1060

Toxic effects of substances chiefly nonmedicinal as to source

405

1.76

4.88

1.1

1.3

2.28

2.07

mmol/l

0.31

380

Corneal ulcer

107

680

1.58

4.87

1.3

2.15

2.03

mmol/l

0.37

635

Other skin changes

103

649

1.59

4.86

1.3

2.05

2.17

mmol/l

0.50

605

Abnormal blood-pressure reading, without diagnosis

143

2.33

4.85

1.3

1.2

1.96

2.09

mmol/l

0.49

132

Diabetic nephropathy

519

1.66

4.85

1.1

1.3

2.47

2.34

mmol/l

0.15

477

Use of other anti-dementia drugs

118

613

1.55

4.85

1.1

1.2

1.97

2.36

mmol/l

5.20

108

550

Use of memantine

118

613

1.55

4.85

1.1

1.2

1.97

2.36

mmol/l

5.20

108

550

Lagophthalmos

4.94

4.84

1.3

1.1

3.11

1.87

mmol/l

0.92

Other (not insulin) diabetes medications

529

2526

1.23

4.76

1.2

1.3

2.28

2.05

mmol/l

3.36

485

2351

Endometriosis

180

733

1.43

4.70

1.3

1.2

2.01

2.03

mmol/l

0.07

167

680

Other and unspecified injuries of head

224

2.02

4.70

1.2

1.3

2.02

2.14

mmol/l

0.26

211

Bacterial, viral and other infectious agents, including avohilmo

308

1.86

4.70

1.1

1.3

1.98

2.04

mmol/l

0.13

289

Oxicams

110

394

1.59

4.69

1.2

1.3

2.05

2.23

mmol/l

0.52

101

364

Spondylolisthesis/Spondylolysis

562

1.63

4.67

1.2

1.3

2.19

mmol/l

0.01

529

Gout, FINNGEN

137

921

1.48

4.67

1.2

2.26

2.24

mmol/l

0.04

128

854

Ulcer of lower limb, not elsewhere classified

463

1.69

4.67

1.2

1.3

2.61

2.22

mmol/l

1.13

434

Cholelithiasis, broad definition with cholecystitis

462

2477

1.24

4.67

1.2

1.3

2.16

2.12

mmol/l

0.25

432

2297

Other disorders of white blood cells

159

2.22

4.63

1.2

1.3

2.16

2.01

mmol/l

0.25

148

Neuromyelitis optica

10.71

4.60

1.0

1.5

2.06

2.20

mmol/l

—

COPD (mode)

127

657

1.51

4.60

1.3

1.2

2.09

2.22

mmol/l

0.92

117

619

Allergic rhinitis

180

1270

1.40

4.59

1.2

1.3

1.77

1.97

mmol/l

2.96

168

1187

Assault by bodily force

275

1.90

4.58

1.2

1.4

1.88

1.94

mmol/l

0.20

257

Arthrosis

365

1565

1.28

4.58

1.2

1.3

2.11

2.13

mmol/l

0.09

345

1443

Bacterial pneumonia (organism specified)

221

1477

1.36

4.56

1.4

1.3

2.24

2.12

mmol/l

0.39

195

1371

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

118

754

1.52

4.56

1.4

1.3

2.85

2.21

mmol/l

3.14

111

699

Bacterial, viral and other infectious agents

283

1.89

4.54

1.2

1.3

2.03

2.06

mmol/l

0.08

265

Acute laryngitis and tracheitis

400

1.73

4.54

1.1

1.3

1.94

1.85

mmol/l

0.32

375

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

490

1.66

4.53

1.3

1.2

2.57

2.19

mmol/l

0.92

459

Lateral epicondylitis

415

1.72

4.51

1.3

1.4

1.90

2.10

mmol/l

1.65

388

Lesion of ulnar nerve

438

1.70

4.49

1.1

1.3

1.94

2.08

mmol/l

0.89

411

Crohn's disease of small intestine

235

1.97

4.49

1.3

2.01

1.98

mmol/l

0.06

221

Inflammatory bowel disease

175

1251

1.40

4.48

1.3

1.95

2.03

mmol/l

0.54

168

1171

Localized swelling, mass and lump of skin and subcutaneous tissue

163

1151

1.42

4.47

1.3

2.04

2.12

mmol/l

0.28

151

1074

Other obstetric conditions, not elsewhere classified

196

895

1.39

4.36

1.4

1.2

1.79

1.81

mmol/l

0.08

186

833

Burns and corrosions

488

1.65

4.35

1.1

1.3

2.07

mmol/l

0.02

457

Other coagulation defects

238

1.95

4.34

1.5

1.3

2.08

1.98

mmol/l

0.35

223

Nonsuppurative otitis media

135

800

1.47

4.34

1.1

1.2

2.23

1.93

mmol/l

0.94

128

743

Asthma, hospital admissions , main diagnosis only

448

3169

1.23

4.34

1.3

1.2

1.98

2.09

mmol/l

0.94

411

2947

Diseases of arteries, arterioles and capillaries

325

1865

1.28

4.31

1.2

1.3

2.29

2.18

mmol/l

0.69

299

1732

Biological medication for rheuma

106

693

1.54

4.31

1.3

2.36

1.98

mmol/l

0.68

648

Dermatographic urticaria

225

1.97

4.30

1.3

1.4

2.04

1.95

mmol/l

0.11

211

Benign neoplasm: Colon

266

1914

1.31

4.27

1.2

1.3

2.09

2.24

mmol/l

1.30

245

1778

Infective dermatitis

355

1.76

4.26

1.1

1.3

2.03

2.09

mmol/l

0.29

331

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

511

2657

1.22

4.24

1.2

1.3

2.20

2.12

mmol/l

0.52

481

2456

Superficial injury of hip and thigh

484

1.64

4.23

1.2

1.3

2.08

2.14

mmol/l

0.19

451

Cholelithiasis

441

2443

1.23

4.22

1.2

1.3

2.16

2.12

mmol/l

0.23

410

2265

Atrial fibrillation and flutter

132

577

1.48

4.22

1.1

2.41

1.98

mmol/l

1.69

120

542

Dipeptidyl peptidase 4 (DPP-4) inhibitors

266

1597

1.31

4.22

1.2

1.3

2.51

2.15

mmol/l

3.35

243

1489

Seborrhoeic dermatitis

320

1.79

4.19

1.7

1.3

2.24

2.06

mmol/l

0.29

296

Fissure and fistula of anal and rectal regions

125

851

1.47

4.19

1.2

1.3

2.08

2.12

mmol/l

0.12

115

796

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

192

879

1.38

4.18

1.4

1.2

1.80

1.81

mmol/l

0.04

182

818

Glucosamine medication

209

1238

1.35

4.14

1.3

2.41

2.28

mmol/l

0.40

195

1141

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

163

1169

1.40

4.13

1.3

2.06

2.03

mmol/l

0.09

158

1101

Phlebitis and thrombophlebitis (not including DVT)

116

781

1.49

4.12

1.2

1.3

2.31

2.08

mmol/l

0.92

106

738

Other specified/unspecified inflammatory spondylopathies

141

2.22

4.12

1.3

1.4

1.87

1.99

mmol/l

0.54

136

Benign neoplasm of colon, rectum, anus and anal canal

312

2072

1.27

4.12

1.2

1.3

2.12

2.22

mmol/l

0.63

287

1925

Biguanides

514

2561

1.21

4.11

1.2

1.3

2.31

2.07

mmol/l

2.36

471

2383

Persistent delusional disorders

222

1.95

4.10

1.3

2.49

2.01

mmol/l

0.63

206

Ischemic heart diseases

429

2071

1.23

4.08

1.2

1.3

2.23

2.17

mmol/l

0.31

399

1920

Agoraphobia

2.58

4.06

1.1

1.2

2.02

1.89

mmol/l

0.28

5-aminosalicylic acid

111

744

1.50

4.04

1.4

1.3

1.96

2.00

mmol/l

0.18

106

699

Other/unspecified rheumatoid arthritis

361

1.73

4.04

1.3

2.42

2.27

mmol/l

0.42

335

Statin medication

375

1688

1.25

4.02

1.2

1.3

2.05

2.06

mmol/l

0.06

342

1573

Amenorrhoea

238

1.90

4.01

1.2

1.3

2.10

1.92

mmol/l

0.27

221

Other diseases of lip and oral mucosa

224

1698

1.32

3.99

1.3

2.10

mmol/l

0.01

196

1587

Redundant prepuce, phimosis and paraphimosis

101

656

1.52

3.95

1.3

2.35

2.20

mmol/l

0.20

611

Other enthesopathies

151

1078

1.40

3.94

1.3

1.96

2.18

mmol/l

3.17

140

1008

Other specified and unspecified personality disorders

327

1.75

3.93

1.2

1.4

1.88

2.00

mmol/l

0.39

306

L04AC Interleukin inhibitors

233

1.90

3.92

1.4

1.3

1.98

1.99

mmol/l

0.03

218

Disorders of parathyroid gland

605

1.54

3.92

1.2

1.3

1.96

2.19

mmol/l

1.48

558

Thyrotoxicosis, other and/or unspecified

107

717

1.50

3.91

1.5

1.3

2.34

2.06

mmol/l

0.94

672

Wide developmental disorders, excluding more controls

2.66

3.90

1.2

1.3

1.50

1.86

mmol/l

1.86

Disorders of phosphorus metabolism and phosphatases

7.53

3.90

1.3

1.0

2.01

1.75

mmol/l

—

Disease of hard tissues of teeth, NOS

269

1084

1.30

3.88

1.3

1.2

2.09

2.14

mmol/l

0.24

249

1006

Osteomyelitis

186

2.00

3.83

1.2

2.50

2.20

mmol/l

0.72

177

Endometriosis of pelvic peritoneum

515

1.56

3.83

1.2

1.3

1.79

2.06

mmol/l

1.68

478

Thyroiditis, ILD-related definition

360

1.70

3.81

1.5

1.3

1.98

mmol/l

0.00

337

Otitis externa

126

878

1.44

3.79

1.1

1.3

2.10

2.06

mmol/l

0.08

115

828

False labour

174

786

1.38

3.79

1.2

1.3

1.77

1.94

mmol/l

1.51

166

727

Other and unspecified psoriasis

215

1.92

3.77

1.2

1.3

1.90

2.21

mmol/l

1.47

201

Psoriasis

148

1064

1.40

3.74

1.2

1.3

2.08

mmol/l

0.01

139

1002

Other cataract

211

1186

1.32

3.69

1.3

2.22

2.25

mmol/l

0.13

197

1096

Colonic or urogenital fistula

138

983

1.41

3.69

1.3

2.13

2.12

mmol/l

0.02

128

924

Atrial fibrillation and flutter with reimbursement

101

421

1.51

3.67

1.1

1.2

2.51

2.01

mmol/l

1.45

395

Injuries to the elbow and forearm

381

2664

1.23

3.66

1.2

1.3

2.04

2.08

mmol/l

0.31

345

2483

Type 2 diabetes, definitions combined

497

2409

1.20

3.64

1.3

2.29

2.05

mmol/l

3.83

455

2244

Additional codes for the location of defect, injury or illness

183

1.98

3.63

1.1

1.3

1.63

2.05

mmol/l

4.81

170

Malignant melanoma, including Hilmo

536

1.55

3.63

1.3

1.2

2.14

2.19

mmol/l

0.19

501

Congenital hydrocephalus

8.09

3.60

1.3

1.2

1.75

1.85

mmol/l

—

Seronegative rheumatoid arthritis

336

1.70

3.59

1.2

1.4

2.26

2.09

mmol/l

0.43

319

Persons encountering health services for specific procedures, not carried out

262

1.80

3.59

1.1

1.2

1.92

2.01

mmol/l

0.27

246

Obsessive-compulsive disorder

212

1.90

3.57

1.1

1.2

1.74

1.88

mmol/l

0.64

196

Iron deficiency

2.41

3.57

1.2

1.5

1.65

1.75

mmol/l

0.35

Chronic gastritis

120

840

1.43

3.55

1.2

1.3

2.13

2.25

mmol/l

0.44

108

780

Gout, idiopatic and unspecified

115

799

1.44

3.54

1.2

2.30

2.28

mmol/l

0.06

107

743

Other and unspecified disorders of binocular movement

6.34

3.53

1.1

1.2

1.69

1.80

mmol/l

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

10.35

3.53

1.2

1.5

1.98

1.86

mmol/l

—

DVT of lower extremities

588

1.52

3.52

1.2

1.3

2.26

2.14

mmol/l

0.34

555

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

161

1187

1.36

3.51

1.3

2.32

2.07

mmol/l

1.46

148

1114

Glucagon-like peptide-1 (GLP-1) analogues

161

1187

1.36

3.51

1.3

2.32

2.07

mmol/l

1.46

148

1114

Soft tissue disorders related to use, overuse and pressure

134

959

1.40

3.50

1.3

2.21

mmol/l

0.00

120

892

Open wound of ankle and foot

354

1.67

3.50

1.3

1.80

2.05

mmol/l

1.77

333

Intestinal stricture

145

1052

1.38

3.50

1.2

1.3

1.99

2.18

mmol/l

2.04

132

983

Other and unspecified disorders of white blood cells

112

2.25

3.49

1.2

1.4

2.31

2.00

mmol/l

0.35

105

Malignant melanoma

471

1.58

3.47

1.3

1.2

2.17

2.22

mmol/l

0.16

442

Type 2 diabetes, definitions combined, including avohilmo

499

2418

1.19

3.45

1.3

2.31

2.04

mmol/l

4.09

455

2255

Otitis media, unspecified

384

1.61

3.41

1.1

1.3

1.88

1.86

mmol/l

0.04

355

Other and unspecified local infections of skin and subcutaneous tissue

327

1.69

3.39

1.3

1.83

2.11

mmol/l

2.05

307

Type 2 diabetes, strict (exclude DM1)

498

2433

1.19

3.38

1.3

2.29

2.05

mmol/l

3.71

456

2266

Palmar fascial fibromatosis [Dupuytren]

413

1.60

3.33

1.1

1.2

2.25

2.42

mmol/l

0.50

386

Viral pneumonia (known virus, not influenza)

2.56

3.30

1.4

1.3

2.46

1.96

mmol/l

0.81

Metabolic disorder, other/unspecified

8.96

3.30

1.0

1.6

1.68

1.50

mmol/l

—

Coeliac disease

399

1.61

3.29

1.1

1.3

2.00

2.08

mmol/l

0.28

372

Fibroblastic disorders

103

712

1.45

3.29

1.2

1.3

2.11

2.29

mmol/l

0.90

664

Excessive attrition of teeth

331

2675

1.23

3.26

1.2

1.3

1.93

2.06

mmol/l

1.91

306

2501

Appendectomy

345

2696

1.22

3.21

1.2

1.3

1.95

2.09

mmol/l

1.54

321

2511

Heart failure,strict

242

1327

1.27

3.21

1.4

1.3

2.24

2.22

mmol/l

0.07

224

1231

Cervicobrachial syndrome

103

717

1.44

3.18

1.6

1.3

1.90

2.18

mmol/l

2.99

675

Spondylopathies (FG)

474

1.55

3.17

1.4

1.3

2.13

1.99

mmol/l

0.42

448

Anorexia (incl.atypical)

186

1.89

3.14

1.1

1.3

1.87

1.86

mmol/l

0.04

174

Paralytic ileus and intestinal obstruction

116

827

1.40

3.13

1.3

1.94

2.26

mmol/l

4.06

106

766

IBD patients in KELA-register

125

905

1.39

3.11

1.3

1.91

2.01

mmol/l

0.49

120

846

Other local infections of skin and subcutaneous tissue

351

1.63

3.10

1.2

1.3

1.85

2.11

mmol/l

1.80

329

Artrosis, including avohilmo

448

2057

1.19

3.10

1.1

1.3

2.05

2.12

mmol/l

0.49

417

1916

Syndactyly, including avohilmo

7.78

3.08

1.0

1.9

3.00

1.97

mmol/l

—

Chronic rhinitis, nasopharyngitis and pharyngitis

162

1222

1.33

3.08

1.3

1.95

2.09

mmol/l

0.58

149

1153

Hypertensive encephalopathy

7.77

3.08

1.3

1.1

1.80

1.88

mmol/l

—

7.73

3.08

1.3

1.88

1.70

mmol/l

—

Non-ischemic cardiomyopathy

148

870

1.35

3.07

1.4

1.3

2.16

2.22

mmol/l

0.28

137

812

Vascular dementia (undefined)

2.61

3.07

1.3

1.1

2.30

2.23

mmol/l

0.09

Pollen allergy

111

778

1.41

3.07

1.2

1.3

1.67

1.85

mmol/l

3.09

102

721

Fracture of femur

117

755

1.40

3.06

1.3

1.2

2.17

2.21

mmol/l

0.15

106

706

Fall involving bed

2.45

3.05

1.6

1.1

2.14

2.09

mmol/l

0.07

Spontaneous abortion

231

1217

1.27

3.04

1.3

1.98

2.03

mmol/l

0.28

213

1134

Other abnormal products of conception

170

842

1.33

3.04

1.3

1.79

1.95

mmol/l

2.23

161

789

Coxarthrosis

234

1189

1.27

3.04

1.2

1.3

2.19

2.21

mmol/l

0.05

217

1098

Rheumatoid arthritis, including avohilmo

181

1392

1.30

3.02

1.2

1.3

2.22

2.12

mmol/l

0.57

164

1296

Congenital malformations of the circulatory system

497

1.51

3.01

1.5

1.3

2.09

2.03

mmol/l

0.18

468

Phobic anxiety disorders

455

1.54

3.01

1.3

1.2

1.83

1.91

mmol/l

0.46

425

Hereditary hypogammaglobulinemia

10.32

3.00

1.4

1.0

1.69

1.67

mmol/l

—

Thyrotoxicosis

126

921

1.37

2.97

1.4

1.3

2.31

2.06

mmol/l

1.01

118

862

Salpingitis and oophoritis

563

1.48

2.96

1.7

1.3

2.10

mmol/l

0.01

528

Gingivitis and periodontal diseases

526

2318

1.17

2.96

1.2

1.3

2.01

2.12

mmol/l

1.28

487

2147

Other sexually transmitted chlamydial diseases, including avohilmo

395

1.58

2.95

1.2

1.3

1.83

1.77

mmol/l

0.18

365

Open wound of forearm

325

1.64

2.95

1.3

1.4

1.92

2.08

mmol/l

0.77

307

Follicular lymphoma, hilmo

114

2.12

2.95

1.2

2.02

2.04

mmol/l

0.07

105

Sulfasalazine

135

1000

1.35

2.93

1.2

1.3

2.38

2.06

mmol/l

0.73

129

937

Other otitis externa (chronic)

206

1.81

2.90

1.1

1.3

2.02

1.99

mmol/l

0.09

191

Disorders of other and unspecified cranial nerves

5.53

2.89

1.6

1.2

1.62

2.03

mmol/l

—

Allergic urticaria

266

1.70

2.88

1.2

1.3

1.86

1.95

mmol/l

0.41

244

Maternal care for other conditions predominantly related to pregnancy

116

821

1.38

2.85

1.1

1.3

1.96

1.89

mmol/l

0.24

109

771

Polyarthrosis

584

1.44

2.84

1.3

1.4

2.06

2.20

mmol/l

0.90

542

Inflammatory bowel disease, strict (require KELA)

125

921

1.36

2.83

1.3

1.91

2.01

mmol/l

0.48

120

860

Fracture at wrist and hand level

178

1375

1.29

2.82

1.2

1.3

1.87

2.06

mmol/l

2.49

164

1289

Pustulosis palmaris et plantaris

123

2.05

2.82

1.1

1.2

2.00

2.02

mmol/l

0.05

116

Follicular cysts of skin and subcutaneous tissue

661

1.43

2.80

1.3

1.2

2.05

2.10

mmol/l

0.20

617

Retinal detachments and breaks

161

1234

1.31

2.78

1.2

1.3

2.22

mmol/l

0.01

148

1142

Diseases of salivary glands

165

1269

1.30

2.78

1.2

1.3

1.96

2.08

mmol/l

0.57

154

1182

Other arthrosis

251

1353

1.24

2.77

1.2

1.3

2.14

2.17

mmol/l

0.13

237

1251

Eustachian salpingitis and obstruction

300

1.64

2.77

1.2

1.4

1.83

1.91

mmol/l

0.36

286

Dermatophytosis, including avohilmo

343

2806

1.20

2.76

1.2

1.3

2.17

2.09

mmol/l

0.25

317

2612

Malignant melanoma of skin, including Hilmo

434

1.53

2.76

1.4

1.2

2.14

2.22

mmol/l

0.28

408

Early onset COPD

101

722

1.40

2.75

1.4

1.3

2.25

2.18

mmol/l

0.17

679

Diverticular disease of intestine

335

1728

1.21

2.75

1.2

1.3

2.17

2.25

mmol/l

0.47

311

1604

Fracture of lower leg, including ankle

274

2200

1.22

2.73

1.2

1.3

2.16

2.14

mmol/l

0.08

260

2036

Gonarthrosis

300

1389

1.22

2.71

1.2

1.3

2.17

mmol/l

0.03

277

1285

Pregnancy with abortive outcome

327

1408

1.21

2.69

1.4

1.2

1.93

2.06

mmol/l

1.72

299

1306

Iron deficiency anaemia secondary to blood loss (chronic)

502

1.48

2.68

1.3

1.2

2.19

2.20

mmol/l

0.04

467

Coxarthrosis [arthrosis of hip](FG)

251

1397

1.24

2.66

1.2

1.3

2.18

2.21

mmol/l

0.09

232

1298

Other inflammation of eyelid

487

1.48

2.65

1.2

1.3

1.99

2.16

mmol/l

0.69

454

Chronic periodontitis, complicated

278

2230

1.22

2.62

1.3

2.25

2.16

mmol/l

0.40

262

2078

Recurrent dislocation of patella

162

1.86

2.62

1.2

1.4

2.08

1.84

mmol/l

0.26

153

Failed induction of labour

236

1.71

2.61

1.1

1.3

1.65

1.77

mmol/l

0.82

223

Atopic dermatitis, strict definition with reimbursement

162

1205

1.29

2.61

1.2

1.3

1.90

mmol/l

0.01

154

1130

Conjunctivitis (acute, non atopic), including avohilmo

543

2842

1.15

2.61

1.2

1.3

2.01

2.12

mmol/l

1.26

512

2638

Osteomyelitis of vertebra

7.38

2.57

1.0

1.4

1.89

2.09

mmol/l

—

Effects of foreign body entering through natural orifice

122

913

1.34

2.53

1.2

1.3

2.20

2.04

mmol/l

0.46

106

857

Nonalcoholic fatty liver disease

355

1.56

2.53

1.7

1.2

2.33

2.04

mmol/l

0.96

334

Medical abortion

310

1392

1.21

2.50

1.3

1.2

1.99

2.06

mmol/l

0.61

281

1291

Acute appendicitis, no complications

289

2387

1.20

2.50

1.2

1.3

1.88

2.08

mmol/l

2.53

269

2232

Benign neoplasm: Brain, unspecified

4.48

2.49

1.3

2.56

1.86

mmol/l

—

Schizophrenia

552

1.44

2.48

1.2

1.3

1.98

1.99

mmol/l

0.03

514

Malignant neoplasm of skin, including Hilmo

235

1276

1.23

2.46

1.3

2.20

2.16

mmol/l

0.20

217

1184

Other follicular disorders

248

1.66

2.46

1.4

1.3

2.02

1.96

mmol/l

0.09

232

Other maternal disorders predominantly related to pregnancy

286

1481

1.21

2.43

1.3

1.93

2.04

mmol/l

1.11

268

1378

Noninflammatory disorders of female genital tract

199

792

1.26

2.42

1.2

1.92

2.00

mmol/l

0.59

187

737

Moderate visual impairment, monocular

5.13

2.42

1.7

1.2

1.95

1.70

mmol/l

—

Other specified disorders of muscle

2.30

2.42

1.1

1.7

1.85

2.15

mmol/l

1.54

Meningococcal infection, including avohilmo

5.08

2.41

1.2

7.47

1.74

mmol/l

—

Postmenopausal osteoporosis with pathological fracture

167

1.81

2.40

1.2

2.13

2.22

mmol/l

0.22

158

Ovarian cyst

168

750

1.28

2.39

1.2

1.85

2.02

mmol/l

2.13

155

695

Tumor necrosis factor alpha inhibitors

624

1.40

2.38

1.3

2.45

1.98

mmol/l

0.70

583

Valgus deformity, not elsewhere classified

4.19

2.37

1.0

1.4

1.58

1.85

mmol/l

—

Diseases of appendix

386

2952

1.17

2.37

1.2

1.3

1.93

2.10

mmol/l

2.10

357

2749

Hyperparathyroidism

527

1.43

2.35

1.2

1.3

2.01

2.21

mmol/l

0.92

488

Fracture of shoulder and upper arm

166

1310

1.27

2.33

1.3

2.26

2.09

mmol/l

0.71

157

1217

Atopic dermatitis

317

2127

1.19

2.31

1.3

1.86

2.01

mmol/l

1.76

302

1987

Percutaneous Coronary Intervention

381

1980

1.17

2.27

1.2

1.3

2.22

2.18

mmol/l

0.19

356

1836

Monoarthritis, not elsewhere classified

120

1.93

2.26

1.1

1.5

2.04

2.10

mmol/l

0.09

112

Ganglion

101

750

1.35

2.25

1.3

1.4

1.86

2.11

mmol/l

3.37

699

Infective bursitis

2.29

2.25

1.1

1.2

2.84

2.32

mmol/l

0.22

Haemorrhoids and perianal venous thrombosis

156

1221

1.27

2.24

1.3

2.11

2.23

mmol/l

0.43

145

1130

Chronic periodontitis, including avohilmo

513

2864

1.14

2.23

1.2

1.3

2.13

2.12

mmol/l

0.01

482

2651

Toxic effect of organic solvents

5.70

2.23

1.0

1.4

2.44

2.07

mmol/l

—

Other/unspecified mastoiditis and related conditions

5.67

2.22

1.0

1.6

4.84

2.04

mmol/l

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

5.65

2.22

1.2

1.0

1.79

mmol/l

—

Appendicitis, broad definition

381

2940

1.16

2.21

1.2

1.3

1.93

2.10

mmol/l

2.04

352

2738

Heart failure, strict

259

1495

1.20

2.19

1.4

1.3

2.25

mmol/l

0.01

240

1389

Coronary revascularization (ANGIO or CABG)

380

1980

1.17

2.17

1.2

1.3

2.21

2.18

mmol/l

0.15

355

1836

Acute mastoiditis

3.74

2.16

1.4

1.3

5.19

1.97

mmol/l

—

Endometriosis ASRM stages 1,2

662

1.36

2.15

1.2

1.3

1.78

1.97

mmol/l

1.17

621

Malignant neoplasm of prostate

112

498

1.33

2.15

1.3

1.2

2.16

2.23

mmol/l

0.23

104

467

Pustular psoriasis

144

1.82

2.15

1.1

1.3

2.01

2.11

mmol/l

0.25

136

Other disorders of conjunctiva

477

1.43

2.14

1.1

1.3

1.80

2.17

mmol/l

4.63

444

Major coronary heart disease event

406

2097

1.16

2.13

1.2

1.3

2.21

2.19

mmol/l

0.12

378

1945

Non-allergic asthma (mode), excluding more controls

489

1.42

2.13

1.2

1.81

2.08

mmol/l

2.69

460

Lichen simplex chronicus and prurigo

189

1.70

2.13

1.6

1.2

2.96

2.04

mmol/l

0.42

176

malignant neoplasm of male genital organs

117

534

1.32

2.12

1.2

2.24

2.20

mmol/l

0.11

109

501

All-cause Heart Failure

256

1484

1.20

2.11

1.4

1.3

2.26

2.24

mmol/l

0.06

238

1380

Viral warts, including avohilmo

109

829

1.32

2.09

1.2

1.3

1.98

1.97

mmol/l

0.03

103

766

Malignant neoplasm of prostate, including Hilmo

113

504

1.33

2.09

1.3

1.2

2.16

2.22

mmol/l

0.20

105

473

Hernia

477

2778

1.14

2.07

1.2

1.3

2.16

2.12

mmol/l

0.21

442

2578

Acquired clawhand, clubhand, clawfoot and clubfoot

4.08

2.05

1.2

1.3

1.83

2.13

mmol/l

—

Placenta praevia

190

0.42

2.05

1.3

1.84

1.79

mmol/l

—

176

Precocious central puberty

4.07

2.05

2.2

1.2

1.89

1.75

mmol/l

—

Cardiodefibrillation

1231

0.75

2.04

1.1

1.3

2.34

2.24

mmol/l

0.16

1143

Disorders of breast

243

1786

1.20

2.04

1.2

1.3

1.96

2.07

mmol/l

1.04

222

1660

Non-allergic asthma (mode)

494

1.41

2.03

1.2

1.81

2.07

mmol/l

2.62

464

Periodontitis

510

2866

1.13

2.02

1.2

1.3

2.13

2.12

mmol/l

0.02

479

2653

Peritonsillar abscess

103

782

1.32

2.01

1.2

1.3

1.93

2.07

mmol/l

0.63

739

Other acute viral hepatitis

2.84

2.01

1.0

1.4

1.81

mmol/l

—

Conduction disorders

136

857

1.27

1.98

1.2

1.3

2.16

mmol/l

0.01

125

800

COPD-related respiratory insufficiency

337

1.49

1.96

1.2

2.05

2.22

mmol/l

0.62

313

Diving or jumping into water causing injury other than drowning or submersion

4.63

1.95

1.0

1.2

1.90

1.72

mmol/l

—

Acne conglobata

4.62

1.95

1.8

1.3

1.96

1.71

mmol/l

—

Synovial hypertrophy, not elsewhere classified

4.59

1.94

1.0

1.5

1.54

2.20

mmol/l

—

Acute appendicitis

355

2854

1.15

1.93

1.2

1.3

1.89

2.11

mmol/l

4.01

331

2660

Other or ill-defined heart diseases

172

1.69

1.93

1.1

1.3

2.18

2.10

mmol/l

0.12

166

Myopia

471

1.41

1.92

1.3

1.2

1.93

1.94

mmol/l

0.02

439

Haemorrhage in early pregnancy

137

1056

1.26

1.92

1.2

1.3

1.92

1.99

mmol/l

0.42

128

985

Other and unspecified disorders of vitreous body

188

1512

1.22

1.90

1.2

1.3

2.09

2.26

mmol/l

1.41

176

1405

Valvular heart disease excluding rheumatic fever

212

1255

1.21

1.89

1.3

2.24

2.17

mmol/l

0.30

196

1166

Mixed conductive and sensorineural hearing loss

365

1.46

1.88

1.3

1.2

2.42

2.19

mmol/l

0.32

342

Simple and mucopurulent chronic bronchitis

100

1.91

1.85

1.6

1.3

2.20

2.06

mmol/l

0.27

Malignant melanoma of skin

358

1.46

1.85

1.5

1.2

2.10

2.18

mmol/l

0.30

336

Meningococcal infection

4.22

1.83

1.2

1.3

7.28

1.74

mmol/l

—

Non-rheumatic valve diseases

209

1240

1.20

1.82

1.3

2.24

2.17

mmol/l

0.25

194

1153

Artificial joint operation, meniscal resection

437

2460

1.14

1.82

1.2

1.3

2.16

2.18

mmol/l

0.10

401

2286

Retinal vascular disorders

351

1.46

1.82

1.5

1.2

2.48

2.26

mmol/l

0.28

322

Benign neoplasm of urinary organs

130

1.78

1.81

1.2

1.72

2.07

mmol/l

2.01

122

Trochanteric bursitis

452

1.40

1.80

1.3

1.4

1.92

2.13

mmol/l

1.90

417

Premature rupture of membranes

119

664

1.28

1.79

1.2

1.86

1.91

mmol/l

0.20

114

616

malignant neoplasm of male genital organs, including Hilmo

117

548

1.28

1.78

1.2

2.24

2.19

mmol/l

0.14

109

513

Female genital prolapse

131

576

1.27

1.76

1.2

1.3

2.02

2.13

mmol/l

0.59

121

532

Other disorders of breast

488

1.38

1.76

1.2

1.4

1.86

2.04

mmol/l

1.58

455

Hypoparathyroidism

1.94

1.75

1.1

1.3

1.74

2.01

mmol/l

1.52

Atopic dermatitis, strict definition

155

1235

1.23

1.75

1.2

1.3

1.86

1.91

mmol/l

0.16

149

1161

Malignant neoplasm of small intestine

2.24

1.74

1.1

2.08

2.19

mmol/l

0.15

Testicular hypofunction

110

1.83

1.73

1.0

1.4

1.69

1.97

mmol/l

2.62

104

Injury of nerves at hip and thigh level

3.94

1.73

1.0

1.4

1.68

2.06

mmol/l

—

Other congenital malformations of brain

3.92

1.72

1.2

1.5

1.72

1.75

mmol/l

—

Malignant neoplasm of skin

214

1214

1.19

1.72

1.2

1.3

2.18

2.17

mmol/l

0.05

194

1127

Testicular dysfunction

125

1.77

1.72

1.0

1.4

1.77

1.94

mmol/l

1.08

119

Ischaemic heart disease, wide definition

356

1911

1.15

1.71

1.2

1.3

2.23

2.19

mmol/l

0.22

327

1779

Wide developmental disorders

110

1.82

1.71

1.2

1.50

1.83

mmol/l

2.07

102

Retinal vascular occlusion

348

1.44

1.70

1.5

1.2

2.50

2.26

mmol/l

0.29

320

Vascular diseases of the intestine

1.92

1.70

1.2

2.51

2.11

mmol/l

0.93

Superficial injury of ankle and foot

475

1.37

1.69

1.1

1.3

1.94

1.98

mmol/l

0.08

445

Psoriasis vulgaris

665

1.31

1.68

1.2

1.3

1.96

2.07

mmol/l

0.56

625

Other and unspecified primary disorders of muscles

3.20

1.67

1.0

1.2

1.90

1.81

mmol/l

—

Abnormal results of function studies

284

1.48

1.66

1.2

1.3

1.70

2.16

mmol/l

4.50

271

Labour and delivery complicated by umbilical cord complications

164

0.42

1.66

1.9

1.3

1.97

mmol/l

—

153

Evidence of alcohol involvement determined by level of intoxication

2.83

1.65

1.1

1.2

3.59

1.94

mmol/l

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

112

1.80

1.65

1.2

1.5

1.68

1.85

mmol/l

0.98

105

Hypertension, Pulmonary Arterial

3.61

1.62

1.4

1.3

2.16

1.76

mmol/l

—

Hallux valgus (acquired)

142

825

1.23

1.60

1.2

1.3

2.27

2.14

mmol/l

0.41

128

763

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

275

2279

1.16

1.59

1.3

1.96

2.05

mmol/l

1.00

251

2119

Malignant neoplasm of mesothelium and soft tissue

106

1.80

1.59

1.3

1.2

2.62

2.20

mmol/l

0.66

Lichen planus

413

1.38

1.58

1.3

2.18

2.12

mmol/l

0.17

388

Emergency coronary revascularization (for ACS)

401

2144

1.13

1.56

1.2

1.3

2.21

2.19

mmol/l

0.07

375

1987

Ulcerative colitis

115

922

1.25

1.55

1.3

1.91

2.03

mmol/l

0.84

109

865

Gonarthrosis [arthrosis of knee](FG)

343

1731

1.14

1.54

1.2

1.3

2.17

mmol/l

0.01

315

1614

Varicose veins

268

1750

1.16

1.54

1.3

2.27

2.22

mmol/l

0.25

249

1612

Coronary artery bypass grafting

617

0.74

1.52

1.2

2.49

2.22

mmol/l

0.61

574

Contact with venomous snakes and lizards

2.62

1.52

1.1

1.2

2.01

1.85

mmol/l

—

Chronic tubulo-interstitial nephritis

1.84

1.51

1.1

1.2

1.76

1.98

mmol/l

0.69

Seropositive rheumatoid arthritis

103

814

1.26

1.50

1.1

1.3

2.31

2.16

mmol/l

0.64

761

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.08

1.49

1.2

1.59

1.76

mmol/l

1.39

Malignant neoplasm of other connective and soft tissue

2.01

1.49

1.4

1.1

2.60

2.19

mmol/l

0.45

Pedal cyclist injured in transport accident

107

856

1.25

1.48

1.3

1.96

2.02

mmol/l

0.19

101

799

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

581

1.30

1.48

1.4

1.3

2.06

2.00

mmol/l

0.18

543

Examination and encounter for administrative purposes

202

1.54

1.48

1.1

1.99

2.25

mmol/l

0.70

188

Periapical abscess

222

1906

1.17

1.47

1.3

2.09

2.12

mmol/l

0.11

201

1783

Alzheimer’s disease (Late onset)

508

1.30

1.45

1.2

2.09

2.32

mmol/l

1.46

455

Open wound of lower leg

515

1.32

1.44

1.2

1.3

2.08

2.09

mmol/l

0.02

478

Fall involving playground equipment

3.16

1.44

1.2

1.6

1.72

1.79

mmol/l

—

Acute lymphocytic leukaemia

3.16

1.44

1.8

1.5

1.56

1.96

mmol/l

—

Acute lymphocytic leukaemia, helper endpoint

3.16

1.44

1.8

1.5

1.56

1.96

mmol/l

—

Acute lymphocytic leukaemia, including Hilmo

3.16

1.44

1.8

1.5

1.56

1.96

mmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

156

1303

1.20

1.44

1.1

1.3

2.13

2.18

mmol/l

0.21

144

1219

Helminthiases, including avohilmo

125

1.69

1.43

1.2

1.5

1.74

1.83

mmol/l

0.41

117

AV-block

493

1.30

1.40

1.1

1.2

2.14

2.16

mmol/l

0.07

464

Preterm labour and delivery

116

944

1.23

1.39

1.3

1.97

2.03

mmol/l

0.28

108

880

589

1.29

1.39

1.3

1.2

2.17

2.30

mmol/l

0.66

539

Allergic conjunctivitis

288

2436

1.14

1.38

1.2

1.3

1.95

2.04

mmol/l

1.01

262

2270

Procreative management

165

1144

1.19

1.37

1.2

1.3

1.96

1.99

mmol/l

0.14

152

1063

Diaphragmatic hernia

153

1283

1.19

1.36

1.2

1.3

2.09

2.20

mmol/l

0.40

140

1192

Pre-eclampsia

759

1.25

1.36

1.3

2.20

1.95

mmol/l

0.79

717

Benign neoplasm: Kidney

1.76

1.35

1.2

1.3

1.70

2.09

mmol/l

2.26

Other or unspecified ileus, impaction or obstruction

574

1.29

1.34

1.2

1.3

1.92

2.21

mmol/l

2.92

534

Obstructed labour due to malposition and malpresentation of fetus

831

0.78

1.30

1.2

1.3

2.06

1.92

mmol/l

0.30

780

Impacted cerumen

360

1.36

1.29

1.2

1.3

1.97

2.18

mmol/l

1.15

335

Glaucoma

242

1794

1.15

1.29

1.3

2.20

2.25

mmol/l

0.23

223

1662

Blepharochalasis

121

999

1.21

1.29

1.2

1.3

2.35

2.24

mmol/l

0.29

109

933

Personal history of medical treatment

2.80

1.29

1.0

1.1

1.57

1.97

mmol/l

—

Malignant neoplasm of lip, including Hilmo

2.80

1.29

1.0

1.2

2.06

2.18

mmol/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

281

0.60

1.28

1.2

2.65

2.20

mmol/l

0.60

264

Disturbances of smell and taste

1.72

1.27

1.1

1.4

2.46

2.24

mmol/l

0.12

Perforation of tympanic membrane

336

1.37

1.27

1.2

1.3

2.00

2.14

mmol/l

0.28

310

Malignant neoplasm of pancreas, including Hilmo

230

0.56

1.26

1.0

1.1

2.71

2.31

mmol/l

0.66

213

Injury of eye and orbit

492

1.30

1.26

1.2

2.02

2.03

mmol/l

0.02

465

Polyarthritis, unspecified

107

1.69

1.26

1.3

1.5

3.02

2.10

mmol/l

0.61

101

Infections of genitourinary tract in pregnancy

328

1.38

1.26

1.5

1.2

1.97

1.95

mmol/l

0.06

307

COPD, hospital admissions 3, with asthma pneumonia sepsis

102

710

1.23

1.25

1.4

1.2

2.11

2.31

mmol/l

1.30

660

Burns classified according to extent of body surface involved

2.42

1.25

1.7

1.2

2.07

1.79

mmol/l

—

Right hemicolectomy

157

0.51

1.25

1.1

1.2

2.24

2.18

mmol/l

—

146

Other crystal arthropathies

2.01

1.23

1.0

1.2

1.80

2.14

mmol/l

—

Basal cell carcinoma, including Hilmo

187

1088

1.16

1.22

1.2

1.3

2.16

2.21

mmol/l

0.24

169

1011

Asthma/COPD (KELA code 203)

484

2947

1.10

1.21

1.3

2.00

2.10

mmol/l

0.81

447

2743

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

288

0.62

1.20

1.2

2.61

2.20

mmol/l

0.57

271

Other specified/unspecified hearing loss

263

1.41

1.20

1.3

2.15

2.21

mmol/l

0.07

247

Anomalies of dental arch relationship, including avohilmo

698

1.23

1.19

1.4

1.3

1.77

1.91

mmol/l

1.02

648

Scabies, including avohilmo

603

1.26

1.19

1.2

1.3

1.82

1.89

mmol/l

0.37

559

ILD, hospital admissions

462

1.30

1.18

1.3

1.2

2.29

2.24

mmol/l

0.09

433

Uterine polyps

122

591

1.21

1.18

1.1

1.3

2.09

2.11

mmol/l

0.06

117

547

Thyrotoxicosis with diffuse goitre

480

1.29

1.18

1.4

1.3

2.08

2.02

mmol/l

0.23

448

Malignant neoplasm of small intestine, including Hilmo

1.78

1.17

1.1

1.2

2.03

2.17

mmol/l

0.25

Autism

1.78

1.17

1.0

1.3

1.51

1.88

mmol/l

1.56

Hypertrophy of breast

632

1.25

1.16

1.3

2.01

2.03

mmol/l

0.05

590

Endometriosis ASRM stages 3,4

102

841

1.21

1.14

1.2

1.3

2.02

mmol/l

0.00

783

Autism spe, excluding more controls

1.90

1.11

1.0

1.1

1.55

1.94

mmol/l

1.26

Other benign neoplasms of skin

161

1386

1.16

1.11

1.2

1.3

2.05

2.13

mmol/l

0.36

150

1286

L02BA Anti-estrogens

539

0.74

1.11

1.1

1.4

2.12

2.13

mmol/l

0.02

509

Myocardial infarction, strict

146

1207

0.85

1.09

1.2

1.3

2.31

2.19

mmol/l

0.47

134

1123

Other disorders of pigmentation

128

1.57

1.08

1.1

1.2

1.76

2.10

mmol/l

1.45

120

Atrophic disorders of skin

523

1.26

1.07

1.3

1.4

2.13

2.10

mmol/l

0.07

485

Other disorders of veins

182

1561

1.15

1.07

1.2

1.3

2.04

2.14

mmol/l

0.63

170

1447

Other chronic obstructive pulmonary disease, including avohilmo

224

1624

1.13

1.06

1.3

2.23

2.24

mmol/l

0.04

204

1506

Muscle strain

1.71

1.05

1.1

1.6

1.70

2.17

mmol/l

2.13

Use of rasagiline

1.80

1.05

1.3

1.2

1.97

2.00

mmol/l

0.10

Interstitial lung disease

472

1.27

1.04

1.3

1.2

2.29

2.24

mmol/l

0.09

442

Interstitial lung disease endpoints

472

1.27

1.04

1.3

1.2

2.29

2.24

mmol/l

0.09

442

Other interstitial pulmonary diseases

472

1.27

1.04

1.3

1.2

2.29

2.24

mmol/l

0.10

442

Benign neoplasm of mouth and pharynx

349

1.32

1.04

1.2

1.3

2.16

mmol/l

0.01

327

Other respiratory diseases principally affecting the interstitium

562

1.25

1.02

1.3

2.27

2.22

mmol/l

0.12

527

Melanocytic naevi of trunk

447

1.28

1.02

1.2

1.3

2.21

2.11

mmol/l

0.18

414

Later onset COPD

687

0.81

1.01

1.1

1.2

2.11

2.36

mmol/l

1.56

633

Hallux rigidus

412

1.29

1.01

1.2

1.4

2.74

2.12

mmol/l

0.49

385

In situ neoplasms

172

1502

1.15

1.00

1.3

2.05

2.15

mmol/l

0.56

161

1388

Psoriasis (vulgaris), strict definition

1.62

1.00

1.1

1.3

2.06

1.98

mmol/l

0.20

Basal cell carcinoma

175

1041

1.15

0.98

1.2

1.3

2.17

2.22

mmol/l

0.25

157

968

Benign neoplasm of eye and adnexa

335

1.32

0.98

1.4

1.3

2.30

2.22

mmol/l

0.16

315

Hypertrophy of breast in women and men

729

1.21

0.97

1.4

1.3

2.02

2.03

mmol/l

0.03

679

Idiopathic gout

292

1.34

0.97

1.2

2.30

2.14

mmol/l

0.30

273

HSIL lesion of the cervix uteri, vagina or vulva

794

1.20

0.96

1.3

2.10

1.92

mmol/l

0.47

744

159

1247

1.15

0.95

1.2

1.3

2.11

2.31

mmol/l

1.60

139

1154

Complications of labour and delivery

290

1452

1.11

0.94

1.3

2.01

2.03

mmol/l

0.08

268

1348

Degeneration of macula and posterior pole

190

1293

1.13

0.94

1.2

1.3

2.14

2.27

mmol/l

1.32

178

1190

Contraceptive management

199

1230

1.13

0.93

1.3

1.94

2.03

mmol/l

0.42

185

1145

COPD related to multimorbidity

154

1133

1.15

0.93

1.3

2.23

2.30

mmol/l

0.24

141

1050

Pacemaker

138

1110

1.16

0.92

1.2

2.12

2.26

mmol/l

0.58

123

1026

Glaucoma suspect

147

1279

1.15

0.92

1.3

2.12

2.21

mmol/l

0.50

135

1188

Polypectomy (DHB20)

207

0.63

0.90

1.5

1.2

1.69

2.17

mmol/l

3.09

195

Fracture of forearm

254

2057

1.11

0.89

1.2

1.3

2.08

mmol/l

0.03

232

1918

Recurrent aphthous stomatitis , including avohilmo

501

1.24

0.89

1.4

1.3

1.95

2.12

mmol/l

0.59

466

Lichen planus, including avohilmo

637

1.21

0.89

1.3

2.06

2.17

mmol/l

0.47

601

Abnormal serum enzyme levels

126

1050

1.16

0.88

1.2

1.3

2.30

2.21

mmol/l

0.24

116

977

Coxarthrosis, primary

249

1863

1.11

0.88

1.2

1.3

2.15

2.24

mmol/l

0.42

232

1724

COPD, hospital admission 2, with asthma infections

121

897

1.16

0.87

1.3

1.2

2.13

2.31

mmol/l

1.26

111

834

Carcinoma in situ of skin of ear and external auricular canal

2.01

0.87

1.3

1.1

2.00

2.41

mmol/l

—

Other inflammation of eyelid, including avohilmo

214

1918

1.12

0.86

1.1

1.3

1.97

2.04

mmol/l

0.35

193

1793

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

188

1125

1.13

0.86

1.2

1.3

2.21

2.20

mmol/l

0.05

172

1045

Benign mammary dysplasia

432

1.25

0.85

1.4

2.09

2.17

mmol/l

0.29

405

Pediculosis, acariasis and other infestations, including avohilmo

704

1.19

0.85

1.2

1.3

1.81

1.94

mmol/l

0.97

654

Hypertrichosis

1.68

0.85

1.3

1.5

1.82

1.83

mmol/l

0.03

Later onset COPD, excluding more controls

405

1.22

0.82

1.2

2.10

2.24

mmol/l

0.63

378

Pre-eclampsia or eclampsia

818

1.18

0.82

1.3

2.20

1.95

mmol/l

0.78

770

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

113

1.51

0.82

1.2

1.4

1.77

1.78

mmol/l

0.03

105

Abscess of external ear

1.88

0.82

1.0

1.2

3.85

1.96

mmol/l

—

Ventral hernia

809

1.18

0.82

1.2

1.3

1.92

2.10

mmol/l

2.11

765

Dermatitis due to ingested food

116

1.49

0.81

1.6

1.4

1.61

1.67

mmol/l

0.24

109

Malignant neoplasm of pancreas

177

0.62

0.81

1.0

1.2

2.78

2.29

mmol/l

0.68

164

Acne, including avohilmo

111

774

1.16

0.80

1.3

1.2

1.78

mmol/l

0.00

106

725

Malignant neoplasm of breast, ER-negative, including Hilmo

654

1.19

0.80

1.1

1.3

2.44

2.15

mmol/l

0.66

604

Benign lipomatous neoplasm

123

1072

1.15

0.79

1.2

1.3

2.40

2.12

mmol/l

0.81

113

1008

Coronary atherosclerosis

278

1597

1.10

0.79

1.3

2.23

2.22

mmol/l

0.05

257

1482

Heart failure and bmi 25plus

141

825

1.14

0.78

1.3

2.25

2.29

mmol/l

0.09

131

766

Adenocarcinoma and ductal carcinoma of pancreas

0.51

0.78

1.0

1.2

3.42

2.31

mmol/l

—

Other diseases of gallbladder

115

1.48

0.77

1.3

2.27

2.12

mmol/l

0.29

110

Pericarditis

107

1.50

0.76

1.1

1.3

1.82

2.12

mmol/l

0.74

101

Stomatitis and related lesions

752

1.17

0.74

1.4

1.3

1.98

2.04

mmol/l

0.18

701

All dysplastic lesions of the cervix uteri, vagina or vulva

135

1161

1.14

0.74

1.2

1.3

2.14

1.91

mmol/l

0.80

129

1085

Thoracic aortic aneurysm

468

1.22

0.74

1.2

2.07

2.24

mmol/l

0.84

441

Speech therapy

929

0.85

0.74

1.1

1.3

2.10

2.15

mmol/l

0.15

877

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

2.01

0.73

1.2

1.5

1.64

1.94

mmol/l

—

Foreign body on external eye

543

1.20

0.72

1.1

1.3

2.21

2.03

mmol/l

0.28

508

Benign neoplasm: Stomach

291

1.27

0.70

1.2

1.3

1.88

2.27

mmol/l

2.14

271

Combinations of oral blood glucose lowering drugs

112

981

1.14

0.70

1.3

2.57

2.14

mmol/l

1.94

103

925

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.51

0.69

1.3

1.4

1.52

2.08

mmol/l

2.42

Actinic keratosis

141

1140

1.13

0.69

1.2

2.13

2.31

mmol/l

1.14

122

1054

Benign neoplasm of other and ill-defined parts of digestive system

583

1.19

0.68

1.1

1.3

2.36

2.12

mmol/l

0.41

548

Other malignant neoplasms of skin (=non-melanoma skin cancer)

176

1075

1.11

0.68

1.2

1.3

2.19

2.21

mmol/l

0.09

159

999

Postmenopausal atrophic vaginitis

101

478

1.15

0.66

1.2

1.3

2.05

2.21

mmol/l

1.00

443

Maternal care for other known or suspected fetal problems

118

651

1.14

0.66

1.2

1.3

1.96

1.85

mmol/l

0.34

110

604

Seropositive rheumatoid arthritis, wide

103

902

1.14

0.66

1.1

1.3

2.31

2.12

mmol/l

0.90

842

Malignant neoplasm of rectum

282

0.74

0.65

1.1

1.2

2.52

2.21

mmol/l

0.49

265

Perineal laceration during delivery

610

0.85

0.65

1.1

1.2

1.69

1.81

mmol/l

0.96

576

Abnormal findings in secretions and smears from cervix uteri vagina vulva

232

1564

1.09

0.64

1.3

2.02

2.00

mmol/l

0.10

225

1449

Skin changes due to chronic exposure to nonionizing radiation

145

1177

1.12

0.63

1.2

1.3

2.12

2.31

mmol/l

1.36

125

1088

Cholangitis (primary sclerosing, PSC)

172

1.34

0.63

1.1

1.3

2.16

2.23

mmol/l

0.14

163

Lichen ruber planus, wide definition including periferal and oral lichen planus

784

1.15

0.63

1.3

2.05

2.15

mmol/l

0.49

735

Complications predominantly related to the puerperium

115

1019

1.13

0.63

1.3

1.95

1.96

mmol/l

0.02

105

957

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

104

1.45

0.62

1.0

1.5

2.08

1.90

mmol/l

0.43

Unspecified jaundice

113

1.42

0.61

1.0

1.2

2.88

2.16

mmol/l

0.70

101

Malignant neoplasm of rectum, including Hilmo

345

0.78

0.60

1.1

1.2

2.63

2.26

mmol/l

0.63

325

Malignant neoplasm of breast, ER-positive, including Hilmo

129

858

1.12

0.59

1.2

1.3

2.10

2.14

mmol/l

0.15

117

787

Other and unspecified epidermal thickening

1.53

0.59

1.3

1.4

1.82

1.90

mmol/l

0.18

Lichen sclerosus et atrophicus

345

1.22

0.58

1.2

1.4

2.35

2.15

mmol/l

0.41

325

Obesity, other/unspecified

155

1405

1.10

0.58

1.2

1.3

1.96

1.99

mmol/l

0.12

146

1324

Benign neoplasm of breast

373

1.21

0.57

1.3

2.22

2.09

mmol/l

0.17

351

Pre-eclampsia or poor fetal growth

136

1220

1.11

0.57

1.3

2.03

1.94

mmol/l

0.34

129

1140

Other/unspecified seropositive rheumatoid arthritis

101

895

1.13

0.57

1.1

1.3

2.31

2.11

mmol/l

1.00

835

Malignant neoplasm of breast, HER-negative

616

1.15

0.57

1.1

1.4

2.47

2.18

mmol/l

0.59

568

Polyp of the female genital tract

123

622

1.12

0.56

1.1

1.2

1.86

2.09

mmol/l

2.70

117

577

Pterygium

1.51

0.56

1.5

1.2

1.67

1.98

mmol/l

1.95

COPD

176

1305

1.10

0.56

1.3

2.18

2.26

mmol/l

0.31

162

1214

Lung cancer and mesothelioma

426

1.18

0.56

1.2

2.07

2.20

mmol/l

0.75

402

L02BG Aromatase inhibitors

113

997

1.12

0.56

1.4

1.3

2.15

2.22

mmol/l

0.35

105

918

Ectopic pregnancy

615

1.16

0.56

1.3

2.01

2.07

mmol/l

0.11

575

Other noninflammatory disorders of uterus, except cervix

465

1.15

0.55

1.3

2.21

mmol/l

0.00

430

Malignant neoplasm of breast, HER-positive

128

857

1.11

0.55

1.2

1.3

2.11

2.14

mmol/l

0.14

116

786

Polycystic ovarian syndrome, broad definition

449

1.18

0.55

1.3

1.71

1.78

mmol/l

0.43

422

Other chronic obstructive pulmonary disease

168

1255

1.10

0.54

1.3

2.20

2.24

mmol/l

0.16

155

1168

Impetigo

142

1.34

0.54

1.4

1.67

1.83

mmol/l

0.97

131

Childhood allergy (age < 16)

485

1.16

0.53

1.3

1.2

1.60

1.72

mmol/l

1.13

451

Impacted maxillary molar

231

1.26

0.53

1.2

1.3

1.74

1.77

mmol/l

0.12

214

Melanocytic naevi

137

1243

1.10

0.52

1.1

1.3

2.08

2.03

mmol/l

0.14

124

1170

Clear cell adenocarcinoma of kidney

126

1.35

0.51

1.3

1.2

3.09

2.29

mmol/l

0.80

118

Presence of cardiac and vascular implants and grafts

157

1054

1.10

0.51

1.2

1.3

2.24

2.26

mmol/l

0.06

138

980

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

884

1.12

0.51

1.1

1.3

2.32

2.11

mmol/l

1.04

824

Inguinal hernia

260

1613

1.07

0.49

1.2

1.3

2.19

2.13

mmol/l

0.24

243

1507

Hernia of abdominal wall

195

1805

1.08

0.49

1.2

1.3

2.05

2.14

mmol/l

0.46

180

1682

All dysplastic lesions of the vagina

1.43

0.49

1.2

1.5

2.05

mmol/l

0.00

Long labour

111

848

1.11

0.48

1.2

1.3

1.95

1.90

mmol/l

0.18

104

798

Malignant neoplasm of breast, HER2-negative, including Hilmo

172

1013

1.09

0.48

1.1

1.3

2.24

2.12

mmol/l

0.47

157

933

Malignant neoplasm of breast, including Hilmo

172

1013

1.09

0.48

1.1

1.3

2.24

2.12

mmol/l

0.47

157

933

Caries of enamel

484

3016

1.05

0.47

1.4

1.3

2.02

2.10

mmol/l

0.59

452

2806

Other appendicitis

272

1.22

0.47

1.5

1.3

2.40

2.11

mmol/l

0.25

255

Other diseases of biliary tract

264

1.21

0.45

1.0

1.3

2.20

mmol/l

0.01

246

Premature separation of placenta [abruptio placentae]

1.43

0.45

1.5

1.4

1.99

1.92

mmol/l

0.17

Impacted teeth

734

1.11

0.44

1.6

1.3

1.85

1.79

mmol/l

0.22

687

Ulcerative ileocolitis

129

0.70

0.43

1.1

1.4

2.07

1.90

mmol/l

—

119

Labour and delivery complicated by fetal stress [distress]

703

0.91

0.41

1.3

1.2

1.85

1.82

mmol/l

0.14

660

Ankylosing spondylitis, strict definition

150

0.73

0.41

1.5

1.4

2.70

1.90

mmol/l

0.60

139

Congenital vesicoureteral reflux

0.00

0.41

0.0

1.5

—

1.80

—

Other mosquito-borne viral fevers, including avohilmo

0.00

0.41

0.0

1.4

—

2.02

—

Xanthelasma of eyelid

0.00

0.41

0.0

1.2

—

1.93

—

Benign neoplasm: Rectum, anus and anal canal

661

1.12

0.41

1.2

1.3

1.97

2.21

mmol/l

1.67

620

Primary coxarthrosis, bilateral

104

947

1.10

0.41

1.2

1.3

2.10

2.23

mmol/l

0.73

877

Adjustment and management of implanted device

482

1.14

0.41

1.1

1.2

2.08

2.17

mmol/l

0.19

446

Congenital malformations of oesophagus

0.00

0.41

0.0

1.8

—

1.83

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

150

1.27

0.40

1.4

2.29

2.17

mmol/l

0.10

141

Primary open-angle glaucoma

112

986

1.09

0.40

1.3

1.2

2.14

2.29

mmol/l

0.86

105

909

Malignant neoplasm of bronchus and lung, including Hilmo

538

0.88

0.39

1.2

2.03

2.26

mmol/l

1.50

504

Aortic aneurysm

716

1.11

0.39

1.2

2.06

2.29

mmol/l

1.90

665

Left bundle-branch block

224

1.21

0.38

1.3

1.2

1.96

2.15

mmol/l

0.67

211

Benign neoplasm: Ascending colon

458

1.14

0.37

1.3

1.2

2.09

2.18

mmol/l

0.16

429

Inflammation of lacrimal passages (acute and unspecified)

1.35

0.37

1.4

1.2

2.89

2.04

mmol/l

—

Inflammatory disorders of breast

225

1.20

0.37

1.1

1.3

1.77

1.93

mmol/l

0.85

208

Femoral hernia, unilateral

1.39

0.37

1.3

1.2

1.99

2.03

mmol/l

—

Inguinal of femoral hernia, unilateral

1.39

0.37

1.3

1.2

1.99

2.03

mmol/l

—

Inguinal hernia, unilateral

1.39

0.37

1.3

1.2

1.99

2.03

mmol/l

—

COPD, hospital admissions 1, only main diagnosis

105

982

0.92

0.36

1.3

1.2

2.08

2.29

mmol/l

1.66

909

Umbilical hernia

110

1013

1.09

0.36

1.2

1.3

2.13

2.08

mmol/l

0.14

101

946

Myocardial infarction, without ST-elevation

145

1219

1.07

0.35

1.2

2.29

2.26

mmol/l

0.12

127

1133

Erosion of teeth , including avohilmo

121

1121

1.08

0.34

1.3

1.91

1.98

mmol/l

0.32

112

1053

Benign neoplasm: Pancreas

1.37

0.34

1.1

3.57

2.06

mmol/l

—

Laparoscopic right hemicolectomy

154

1.24

0.34

1.1

1.2

1.96

2.17

mmol/l

1.00

142

Unspecified privation

350

1.14

0.32

2.0

1.3

1.96

2.13

mmol/l

0.50

328

Benign neoplasm: Rectum

587

1.11

0.32

1.2

1.3

1.99

2.22

mmol/l

1.32

550

Peripheral artery disease

158

1170

1.07

0.32

1.3

2.48

2.26

mmol/l

1.03

145

1087

LeFortI or BSSO operation

132

0.76

0.32

1.0

1.4

1.87

1.89

mmol/l

—

125

Scar conditions and fibrosis of skin

128

1.25

0.32

1.4

1.80

1.92

mmol/l

0.32

122

Other pulmonary heart/vessel disease

110

1.27

0.31

1.5

1.2

1.99

2.20

mmol/l

0.47

101

Gonarthrosis,primary

390

2259

1.04

0.31

1.3

2.17

2.21

mmol/l

0.18

352

2107

Malignant neoplasm of breast

165

1000

1.06

0.31

1.2

1.3

2.24

2.12

mmol/l

0.41

150

921

Nonischemic cardiomyopathy

315

1.14

0.30

1.2

2.28

2.11

mmol/l

0.33

302

L02BB Anti-androgens

259

0.85

0.28

1.4

1.2

2.40

2.27

mmol/l

0.21

240

Event of undetermined intent

223

1.17

0.28

1.4

1.73

1.97

mmol/l

1.17

208

Malignant neoplasm of breast, HER2-negative

164

999

1.06

0.28

1.2

1.3

2.24

2.12

mmol/l

0.42

149

920

COPD, early/later onset

169

1342

1.06

0.28

1.3

2.19

2.25

mmol/l

0.21

156

1244

Oesophageal varices

116

0.77

0.27

1.4

1.3

2.26

2.09

mmol/l

—

109

Pregnancy hypertension

180

1527

1.05

0.27

1.3

2.19

1.98

mmol/l

0.99

166

1428

Malignant neoplasm of bronchus and lung

462

0.90

0.26

1.2

2.07

2.29

mmol/l

1.19

431

Status post-ami

640

0.92

0.26

1.1

1.2

2.46

2.21

mmol/l

0.54

593

Other specified disorders of kidney and ureter

1.28

0.26

1.1

1.2

2.25

2.03

mmol/l

0.13

Torsion of ovary, ovarian pedicle and fallopian tube

1.30

0.26

1.3

1.5

1.92

2.15

mmol/l

—

Seborrhoeic keratosis

839

1.07

0.25

1.3

2.22

2.21

mmol/l

0.02

784

Oesophagitis

161

1.18

0.24

1.2

1.92

2.20

mmol/l

0.88

149

Embedded and impacted teeth

125

958

1.06

0.24

1.5

1.3

1.88

1.83

mmol/l

0.18

115

896

100

806

1.07

0.23

1.2

2.17

2.35

mmol/l

1.30

736

Multiple delivery

284

1.13

0.23

1.4

1.3

2.14

1.94

mmol/l

0.36

265

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

198

1643

1.04

0.23

1.3

2.16

2.00

mmol/l

0.78

183

1533

Operations 2 for CAVS

865

0.93

0.23

1.2

2.51

2.29

mmol/l

0.45

799

Calcific aortic valvular stenosis, diagnosis (helper)

865

0.93

0.23

1.3

1.2

2.51

2.29

mmol/l

0.45

799

Calcific aortic valvular stenosis

865

0.93

0.23

1.3

1.2

2.51

2.29

mmol/l

0.45

799

Calcific aortic valvular stenosis, operated

865

0.93

0.23

1.3

1.2

2.51

2.29

mmol/l

0.45

799

Coxarthrosis, primary, with hip surgery

175

1550

1.05

0.23

1.2

1.3

2.20

2.28

mmol/l

0.24

167

1427

Injury of muscle and tendon at hip and thigh level

361

1.11

0.23

1.3

1.92

2.13

mmol/l

0.96

341

Single delivery by caesarean section

419

0.93

0.22

1.7

1.2

1.84

1.90

mmol/l

0.27

389

Unicornuate uterus

0.00

0.21

0.0

1.4

—

2.17

—

Benign neoplasm: Mediastinum

0.00

0.21

0.0

1.2

—

1.93

—

Foreign object accidentally left in body during surgical and medical care

0.00

0.21

0.0

1.3

—

1.74

—

Congenital malformations of ear causing impairment of hearing

0.00

0.21

0.0

1.2

—

1.61

—

Crushing injury of ankle and foot

0.00

0.21

0.0

1.2

—

1.89

—

Chorioretinal scars

0.00

0.21

0.0

1.1

—

2.05

—

Other congenital malformations of kidney

0.00

0.21

0.0

1.3

—

1.66

—

Corneal pigmentations and deposits

0.00

0.21

0.0

1.3

—

1.73

—

Other operation for atrial fibrillation

0.00

0.21

0.0

1.1

—

1.71

—

Other rupture of muscle

0.00

0.21

0.0

1.3

—

2.32

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.21

0.0

1.3

—

2.07

—

Down's syndrome

0.00

0.21

0.0

1.8

—

1.66

—

Hypospadias

0.00

0.21

0.0

1.2

—

1.76

—

Serous carcinoma of ovary, including Hilmo

105

0.76

0.21

1.0

1.2

2.11

2.19

mmol/l

—

Other specified and unspecified disorders of iris and ciliary body

0.00

0.21

0.0

1.2

—

1.85

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.00

0.21

0.0

1.5

—

1.76

—

Calcific aortic valvular stenosis, including rheumatic fever

869

0.94

0.20

1.2

2.50

2.29

mmol/l

0.43

803

Adenocarcinomas of cervix

0.00

0.20

0.0

1.3

—

2.13

—

Diabetes mellitus in pregnancy

146

885

1.05

0.20

1.3

1.2

1.91

1.87

mmol/l

0.15

138

826

Bilateral sagittal split ramus osteotomy operation

111

0.81

0.20

1.0

1.4

1.53

1.91

mmol/l

—

104

COPD, hospital admissions

165

1332

1.04

0.19

1.3

2.17

2.25

mmol/l

0.33

152

1234

Macular hole

165

0.85

0.19

1.0

1.2

1.84

2.31

mmol/l

2.18

152

Ectropion of eyelid

1.22

0.19

1.2

1.1

2.31

2.30

mmol/l

0.01

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

122

0.82

0.19

1.5

1.2

2.03

2.26

mmol/l

—

112

Other hammer toe(s) (acquired)

473

1.08

0.18

1.2

1.4

2.31

2.16

mmol/l

0.29

436

Alcohol-induced acute pancreatitis

109

1.19

0.18

1.0

1.4

1.93

2.04

mmol/l

0.39

101

Bicuspidal aortic valve syndrome

119

1.18

0.17

1.7

1.3

2.45

2.05

mmol/l

0.86

110

Pathological resorption of teeth

119

1.18

0.17

1.5

1.2

2.27

1.91

mmol/l

0.43

112

Adenocarcinoma and papillary adenocarcinoma of stomach

0.75

0.17

1.2

1.96

1.98

mmol/l

—

Angina pectoris

224

1439

1.03

0.16

1.2

1.3

2.22

mmol/l

0.01

203

1334

Renal cell carcinoma of kidney

1.18

0.16

1.3

1.2

2.20

2.05

mmol/l

—

Gestational diabetes (for exclusion)

166

1100

1.04

0.16

1.3

1.90

1.88

mmol/l

0.08

157

1031

Other superficial mycoses, including avohilmo

398

1.08

0.16

1.6

1.3

1.83

1.97

mmol/l

0.55

374

Malignant neoplasm of bladder

158

1.14

0.16

1.1

2.23

2.24

mmol/l

0.01

144

Benign neoplasm: Tongue

0.75

0.15

1.2

1.3

1.80

1.97

mmol/l

—

Dronedarone medication

1.11

0.15

1.1

1.2

2.15

mmol/l

—

ILD-related respiratory insufficiency

1.08

0.14

1.0

1.1

1.89

2.09

mmol/l

—

Pleural plaque without asbestos

0.80

0.14

1.4

1.1

1.95

2.27

mmol/l

—

Other menopausal disorders

554

0.96

0.14

1.3

1.97

2.14

mmol/l

0.99

513

Otosclerosis

223

0.90

0.14

1.5

1.3

2.12

2.22

mmol/l

0.14

207

Single spontaneous delivery

149

815

0.96

0.14

1.2

2.18

2.05

mmol/l

0.48

140

749

Major coronary heart disease event excluding revascularizations

243

1561

1.03

0.14

1.2

1.3

2.29

2.23

mmol/l

0.23

221

1450

Malignant neoplasm of respiratory system and intrathoracic organs

535

1.05

0.14

1.2

2.29

2.26

mmol/l

0.06

501

Unstable angina pectoris

127

1034

0.96

0.13

1.2

1.3

2.25

2.23

mmol/l

0.05

115

959

Medicines for HER+ breast cancer

133

1196

1.04

0.13

1.3

2.10

2.18

mmol/l

0.45

121

1102

Heart failure and coronary heart disease

149

1076

0.97

0.12

1.3

1.2

2.31

2.24

mmol/l

0.23

140

996

Sulfonylureas

110

842

1.04

0.12

1.1

1.2

2.52

2.20

mmol/l

1.35

101

781

Maternal care for known or suspected abnormality of pelvic organs

103

722

0.96

0.12

1.2

1.79

1.93

mmol/l

1.51

671

Primary gonarthrosis, bilateral

198

1615

1.03

0.12

1.3

2.22

2.24

mmol/l

0.07

180

1500

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

210

1.10

0.12

1.3

1.2

2.76

2.11

mmol/l

0.93

198

Medical treatment for female infertility

885

0.96

0.11

1.3

1.2

1.83

1.87

mmol/l

0.25

830

Gonarthrosis, primary, with knee surgery

224

1705

1.02

0.10

1.2

1.3

2.21

2.25

mmol/l

0.15

202

1587

Persons encountering health services in circumstances related to reproduction

248

1696

0.98

0.10

1.4

1.3

2.00

2.06

mmol/l

0.31

231

1576

Secondary right heart disease

1.15

0.10

1.3

1.2

2.05

2.10

mmol/l

0.08

Biomechanical lesions, not elsewhere classified

156

0.90

0.10

1.3

1.4

1.87

2.11

mmol/l

1.31

146

Gestational [pregnancy-induced] hypertension

101

1036

0.97

0.08

1.2

1.3

2.04

1.92

mmol/l

0.40

979

Carbimazole or st.post thyroidectomy, condition for graves disease

765

1.03

0.08

1.4

1.3

2.10

2.05

mmol/l

0.20

717

Benign neoplasm: Duodenum

1.06

0.08

1.6

1.1

2.73

2.05

mmol/l

—

Idiopathic urticaria

1.05

0.08

1.0

1.6

1.84

1.91

mmol/l

—

Loose body in joint

1.05

0.08

1.4

1.3

2.09

2.12

mmol/l

—

Exposure to other and unspecified animate mechanical forces

1.12

0.07

1.3

1.5

2.35

1.83

mmol/l

0.36

Malignant neoplasm of liver and intrahepatic bile ducts

0.82

0.07

1.8

1.1

1.93

2.37

mmol/l

—

Femoral hernia

118

1.10

0.07

1.3

1.2

2.40

2.09

mmol/l

0.34

111

1.05

0.07

1.4

1.3

1.48

1.52

mmol/l

—

Left ventricular outflow tract obstruction, narrow definition

163

0.92

0.07

1.7

1.4

2.40

1.99

mmol/l

0.98

153

Cystic kidney disease

1.03

0.07

1.4

1.2

2.13

1.96

mmol/l

—

Hypertrophic disorders of skin

178

1.07

0.05

1.5

1.3

1.73

2.03

mmol/l

1.10

165

Maternal care related to the fetus and amniotic cavity and possible delivery problems

184

1093

0.99

0.05

1.2

1.3

1.90

1.99

mmol/l

0.49

179

1008

Delivery, wide proxy

130

678

1.02

0.05

1.5

1.2

2.09

2.00

mmol/l

0.50

119

618

Myocardial infarction

185

1276

1.01

0.04

1.2

1.3

2.33

2.18

mmol/l

0.73

169

1183

Leiomyoma of uterus

260

1443

1.01

0.04

1.3

2.09

mmol/l

0.02

242

1332

Postmenopausal bleeding

467

1.02

0.04

1.6

1.3

2.09

2.22

mmol/l

0.61

432

Tooth eruption problems

575

1.02

0.04

1.2

1.3

1.82

1.78

mmol/l

0.08

532

Hypertrophic scar

160

1.06

0.04

1.5

1.3

1.75

1.90

mmol/l

0.47

150

Atherosclerosis, excluding cerebral and coronary sclerosis

138

1070

1.01

0.03

1.3

1.2

2.50

2.28

mmol/l

0.83

126

991

Abrasion of teeth

150

1483

1.01

0.03

1.3

2.08

2.10

mmol/l

0.07

135

1382

Thyrotoxicosis with toxic multinodular goitre

171

1.05

0.03

1.4

1.3

2.52

2.15

mmol/l

0.61

160

Use of ropinirole

102

1.08

0.03

1.2

1.95

2.01

mmol/l

0.12

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

615

1.02

0.02

1.3

1.2

2.23

mmol/l

0.00

574

Other orthopaedic follow-up care

158

0.95

0.02

1.2

1.84

2.13

mmol/l

0.82

150

Other osteochondropathies

232

1.03

0.02

1.4

1.3

1.95

2.00

mmol/l

0.12

216

Myocardial infarction, unclassifiable

563

1.02

0.02

1.1

1.2

2.36

2.27

mmol/l

0.31

524

Other congenital malformations of the digestive system, including avohilmo

166

0.96

0.01

1.3

1.72

1.83

mmol/l

0.37

157

Benign neoplasm: Descending colon

217

0.97

0.01

1.2

2.06

2.27

mmol/l

0.48

203

Single delivery by forceps and vacuum extractor

359

1.01

0.01

1.3

1.2

1.87

1.82

mmol/l

0.15

334

Other specified disorders of external ear

106

0.94

0.01

1.8

1.2

1.83

2.19

mmol/l

—

Cyst of Bartholin Gland

106

0.94

0.01

1.3

1.4

1.70

1.98

mmol/l

—

101

Cardiomyopathy, other and unspecified

246

0.98

0.00

1.1

1.3

2.31

2.08

mmol/l

0.30

235

Other congenital malformations of the digestive system

137

1.01

0.00

1.4

1.3

1.74

1.79

mmol/l

0.14

131

Congenital ovarian cysts

145

0.97

0.00

1.5

1.3

1.76

1.87

mmol/l

0.27

136

Benign neoplasm: Sigmoid colon

627

1.00

0.00

1.2

1.3

2.24

2.20

mmol/l

0.06

590

Other and/or unspecified nontoxic goitre

225

1.02

0.00

1.3

2.08

2.16

mmol/l

0.17

208

Embedded teeth, including avohilmo

355

1.01

0.00

1.3

1.90

1.84

mmol/l

0.07

329

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

465

0.99

0.00

1.2

1.3

1.88

2.15

mmol/l

1.90

436

Delivery

155

819

1.00

0.00

1.4

1.2

2.20

2.04

mmol/l

0.63

143

753

Other secondary coxarthrosis

102

0.98

0.00

1.3

3.25

2.01

mmol/l

—

Carcinoma in situ of other and unspecified sites

108

1.02

0.00

1.2

1.1

2.72

2.26

mmol/l

0.31

100

Ulcer of oesophagus

202

0.99

0.00

1.1

1.2

2.06

2.25

mmol/l

0.62

186

Carcinoma in situ, bladder

101

0.99

0.00

1.2

1.1

2.84

2.15

mmol/l

—

Pregnancy, childbirth and the puerperium

107

560

1.00

0.00

1.5

1.2

2.03

1.96

mmol/l

0.34

512

Benign neoplasm: Rectosigmoid junction

107

1.03

0.00

1.1

2.87

2.09

mmol/l

0.28

Congenital malformations of aortic and mitral valves

137

1.02

0.00

1.7

1.4

2.45

2.02

mmol/l

0.96

128

Crossbite

235

0.98

0.00

1.3

1.51

1.82

mmol/l

3.83

220

Normotensive glaucoma

253

0.99

0.00

1.3

1.2

1.86

2.31

mmol/l

2.68

235

Rubella [German measles], including avohilmo

1.05

0.00

1.2

1.4

1.90

2.08

mmol/l

—

Rubella [German measles]

1.05

0.00

1.2

1.4

1.90

2.08

mmol/l

—

Oesophageal obstruction

1.05

0.00

1.4

1.2

1.84

2.11

mmol/l

—

Benign neoplasm: Scrotum

0.00

0.0

1.2

—

1.70

—

Myasthenia gravis, drug-induced

0.00

0.0

1.0

—

1.73

—

Cleft lip

0.00

0.0

1.5

—

1.62

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.0

1.0

—

1.86

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.0

1.4

—

1.41

—

Telogen effluvium

0.00

0.0

1.4

—

1.70

—

Small cell lung cancer

0.93

0.00

1.2

1.1

2.04

2.53

mmol/l

—

Other and unspecified parapsoriasis

0.00

0.0

1.3

—

1.77

—

Frostbite with tissue necrosis

0.00

0.0

1.5

—

1.71

—

Drug-induced gout

0.00

0.0

1.0

—

1.97

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.0

1.1

—

1.74

—

Diphtheria, including avohilmo

0.00

0.0

1.3

—

1.97

—

Myiasis, including avohilmo

0.00

0.0

1.2

—

1.65

—

Hypospadias with an incomplete glans penis

0.00

0.0

1.0

—

1.82

—

Diphtheria

0.00

0.0

1.3

—

1.97

—

Family history of mental and behavioural disorders

0.00

0.0

1.0

—

1.87

—

Other specified/unspecified disorders of tympanic membrane

0.00

0.0

1.3

—

1.50

—

Femoral hernia, bilateral

0.00

0.0

1.0

—

1.65

—

Small cell lung cancer, including Hilmo

0.93

0.00

1.2

1.1

2.04

2.53

mmol/l

—

Hereditary factor VIII deficiency

0.00

0.0

1.1

—

1.55

—

Epidermolysis bullosa

0.00

0.0

1.3

—

1.48

—

Cyst of spleen

0.00

0.0

1.3

—

1.54

—

Maze procedure for atrial fibrillation

0.00

-0.00

0.0

1.3

—

1.91

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

-0.00

0.0

1.0

—

1.50

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.6

—

1.88

—

Atrioventricular septal defect

0.00

-0.00

0.0

1.8

—

2.18

—

Chronic respiratory disease originating in the perinatal period

0.00

-0.00

0.0

1.7

—

1.43

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

1.0

—

1.14

—

Ototoxic hearing loss

0.00

-0.00

0.0

1.0

—

1.76

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

2.2

—

1.35

—

0.00

-0.00

0.0

1.0

—

1.23

—

Aortic stenosis, including avohilmo

0.00

-0.00

0.0

1.0

—

1.53

—

Eclampsia

0.00

-0.00

0.0

1.0

—

2.25

—

Congenital glaucoma

0.00

-0.00

0.0

1.0

—

1.49

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

-0.00

0.0

1.8

—

1.36

—

Noonan syndrome

0.00

-0.00

0.0

1.4

—

1.39

—

Exclusion endpoint for clefts

0.92

-0.00

1.2

1.3

1.58

1.82

mmol/l

—

Bilateral cryptorchidism (undescended testicles)

0.00

-0.00

0.0

1.0

—

1.28

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.0

—

1.95

—

Aortic stenosis

0.00

-0.00

0.0

1.0

—

1.49

—

Congenital malformations of lung

0.00

-0.00

0.0

1.8

—

1.52

—

Membranous nephropathy

0.00

-0.00

0.0

1.1

—

1.72

—

Congenital malformations of nose, including avohilmo

0.00

-0.00

0.0

1.0

—

1.61

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.0

—

1.92

—

Paget disease

0.00

-0.00

0.0

1.0

—

1.81

—

Other disorders of skin and subcutaneous tissue related to radiation

0.00

-0.00

0.0

1.4

—

1.86

—

Hypertrophy of bone

0.00

-0.00

0.0

1.4

—

2.01

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

2.2

—

1.86

—

Other and unspecified cicatricial alopecia

0.00

-0.00

0.0

1.0

—

1.67

—

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

0.00

-0.00

0.0

1.3

—

2.12

—

Hirsutism, drug-induced

0.00

-0.00

0.0

1.4

—

2.26

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.5

—

1.77

—

Folliculitis decalvans

0.00

-0.00

0.0

1.0

—

1.72

—

Solar urticaria

0.00

-0.00

0.0

1.4

—

1.65

—

Hyperfunction of pituitary gland, other and/or unspecified

0.00

-0.00

0.0

1.3

—

2.00

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.3

—

1.74

—

Corrosions classified according to extent of body surface involved

0.00

-0.00

0.0

1.2

—

1.65

—

Ulcer of oesophagus, drug-induced

0.00

-0.00

0.0

1.1

—

1.95

—

Crohn's disease (strict) with PSC

0.00

-0.00

0.0

1.4

—

2.16

—

Chronic constrictive pericarditis

0.00

-0.00

0.0

1.2

—

2.03

—

Nontoxic diffuse goitre

0.99

-0.00

1.0

1.2

1.50

2.12

mmol/l

—

Maxillary hypoplasia

0.00

-0.00

0.0

1.3

—

1.53

—

Urethral discharge

0.00

-0.00

0.0

1.4

—

1.82

—

Lesion of sciatic nerve

1.00

-0.00

1.4

1.2

1.81

2.05

mmol/l

—

Burn and corrosion of other internal organs

0.00

-0.00

0.0

1.1

—

1.80

—

Malignant neoplasm of oesophagus, including Hilmo

0.91

-0.00

1.0

1.1

1.91

2.29

mmol/l

—

Other degenerative disorders of eyelid and periocular area

0.00

-0.00

0.0

1.2

—

1.65

—

Disorders of glossopharyngeal nerve

0.00

-0.00

0.0

1.0

—

2.21

—

Injury of heart

0.00

-0.00

0.0

1.3

—

1.90

—

Small cell lung cancer, helper endpoint

0.89

-0.00

1.2

1.1

2.04

2.03

mmol/l

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

-0.00

0.0

1.2

—

1.58

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.0

—

1.89

—

Crushing injury of forearm

0.00

-0.00

0.0

1.7

—

2.08

—

Erectile dysfunction, exclusion

0.00

-0.00

0.0

1.3

—

1.77

—

Benign neoplasm: Testis

0.00

-0.00

0.0

1.3

—

1.89

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.2

—

1.93

—

Lipomatosis, not elsewhere classified

0.00

-0.00

0.0

1.7

—

1.72

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.0

—

1.63

—

Other sideroblastic anaemias

0.00

-0.00

0.0

1.0

—

1.66

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.2

—

1.79

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.2

—

1.70

—

Polycythaemia vera

0.92

-0.00

1.4

1.3

2.10

2.15

mmol/l

—

Carcinoma in situ of skin of eyelid, including canthus

0.00

-0.00

0.0

1.0

—

1.95

—

Cleft hard palate NOS

0.00

-0.00

0.0

1.7

—

1.97

—

Injury of muscle and tendon at ankle and foot level

0.92

-0.00

1.1

1.3

1.76

1.92

mmol/l

—

Benign neoplasm: Urethra

0.00

-0.00

0.0

1.2

—

1.59

—

Disorders of purine and pyrimidine metabolism, other/unspecified

0.00

-0.00

0.0

1.5

—

1.66

—

Fractures involving multiple body regions

0.00

-0.00

0.0

1.7

—

1.72

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.4

—

1.70

—

Wilms' tumor, including Hilmo

0.00

-0.00

0.0

1.3

—

1.73

—

Other haemoglobinopathies

0.00

-0.00

0.0

1.4

—

1.70

—

Non-seminoma of testis

0.00

-0.00

0.0

1.3

—

1.57

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

-0.00

0.0

1.8

—

1.94

—

Type 1 diabetes, strict definition, subgroup 2

0.00

-0.00

0.0

1.8

—

2.06

—

General- and plastic-surgery devices associated with adverse incidents

0.00

-0.00

0.0

1.8

—

2.18

—

Hepatocellular carcinoma, including Hilmo

0.91

-0.00

1.5

1.1

1.98

2.41

mmol/l

—

Klinefelter syndrome, karyotype 47 XXY

0.00

-0.00

0.0

1.2

—

1.72

—

Acute alcohol intoxication ICD-9

0.95

-0.00

1.5

1.3

2.63

2.07

mmol/l

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

-0.00

0.0

1.0

—

1.62

—

Other mosquito-borne viral fevers

0.00

-0.00

0.0

1.2

—

1.69

—

Congenital malformation of biliary tract

0.00

-0.00

0.0

1.6

—

1.48

—

Schistosomiasis [bilharziasis], including avohilmo

0.00

-0.00

0.0

1.3

—

1.83

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.6

—

1.86

—

Pneumoconiosis due to dust containing silica

0.00

-0.00

0.0

1.1

—

1.76

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.6

—

1.70

—

Cystic kidney disease, including avohilmo

100

1.00

-0.00

1.4

1.2

2.16

1.95

mmol/l

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate [Moles/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS